Annual Report • Sep 25, 2024
Annual Report
Open in ViewerOpens in native device viewer

Annual Report & Financial Statements for the year ended 31 July 2024


| Strategic Report | |
|---|---|
| Financial summary | 3 |
| Chairman's statement | 4 |
| Manager's review | 6 |
| Equity exposures and portfolio sector analysis Principal portfolio equity holdings |
11 13 |
| Investment record of the last ten years | 16 |
| Business model | 17 |
| Directors | 28 |
| Directors' Report | 29 |
| Statement of Corporate Governance | 35 |
| Report from the Audit Committee | 45 |
| Directors' Remuneration Report | 48 |
| Remuneration Policy | 52 |
| Statement of Directors' Responsibilities in Relation to the Annual Report and Financial Statements |
53 |
| Independent Auditor's Report to the Members | 56 |
| Financial Statements | |
| Statement of Comprehensive Income | 68 |
| Statement of Changes in Equity | 69 |
| Statement of Financial Position | 70 |
| Statement of Cash Flows Notes Forming Part of the Financial Statements |
71 72 |
| Glossary | 90 |
| Notice of AGM | 93 |
| Shareholder Information | 110 |
| Corporate Information | 111 |

| Year to 31 July |
Year to 31 July |
Percentage increase/ |
|
|---|---|---|---|
| Total Return Total return (£'000) |
2024 121,160 |
2023 28,754 |
(decrease) |
| Return per Share | 301.45p | 71.45p | 321.4% |
| 321.9% | |||
| Total revenue return per Share | 1.42p | 3.67p | (61.3%) |
| Dividend per Share | 21.00p | 14.00p | 50.0% |
| Capital | As at 31 July 2024 |
As at 31 July 2023 |
Percentage increase |
| Net assets attributable to equity Shareholders(i) (£'000) | 334,099 | 221,379 | 50.9% |
| Net asset value ("NAV") per Share | 831.24p | 550.79p | 50.9% |
| NAV total return(ii)† | 55.4% | 15.3% | |
| Benchmark performance – total return basis(iii) |
13.8% | 5.1% | |
| Share price | 704.00p | 451.00p | 56.1% |
| Share price (discount)/premium to NAV† | (15.3%) | (18.1%) |
(i) NAV as at 31 July 2024 includes a net £nil in respect of share buybacks (2023: £289,000).
(ii) Total return including dividends reinvested, as sourced from Bloomberg.
(iii) The Company's benchmark is the MSCI UK Investable Market Index ("MXGBIM" or the "benchmark"), as sourced from Bloomberg.
| Ongoing Charges | Year to 31 July 2024 |
Year to 31 July 2023 |
|---|---|---|
| Ongoing charges as a percentage of average net assets*† |
0.47% | 0.54% |
* Based on total expenses, excluding finance costs and certain non-recurring items for the year and average monthly NAV.
† Alternative performance measure. Details provided in the Glossary on pages 90 to 92.
This was the year that broke through previous all-time highs and set new peaks. The performance for this financial year resulted in a NAV total return per Share of 55.4%*. The Manager's multi-year interest in and studying of Artificial Intelligence ("Ai") continues to put the fund in a good position to capitalise on the continuation of the Era of Ai. The conviction of the Manager and Board remains strong that the growth of Ai is in its infancy. The year in financial market terms can be summarised as a story of lowering inflation, slowing economies, geo-political tensions, and the continuing dominance of mega capitalisation equities.
At the year end, the Shares traded at a 15.3% discount to their NAV per Share, compared to a discount of 18.1% in 2023. This was despite the Company buying no shares into Treasury during the year. The Manager subjectively believes that buying back shares to close discounts is akin to "Canute commanding the tide" and that the discount will only close when 10-year Treasury yields are clearly on a downward path and growth shares are back in vogue. We note that the other Investment Trust Companies that focus on investing in Technology are on similar free float adjusted discounts. The Directors and the Managers bought a net total of 389,272 shares (with a value of £2.5m) during the financial year.
We are committed to attracting the best talent that can lead and challenge the direction of the Company. The Manager & the Board invite any interested parties who believe they can add to the diversity of the Board and have some knowledge of Technology investment or operations to indicate their interest in becoming a non-executive director of the Company by emailing them at [email protected]
Our fifty-second Annual General Meeting ("AGM") will be held virtually on 6 November 2024 at 12.00 noon.
We are aware that some shareholders prefer physical AGMs and, although they are materially more expensive, we do see some benefits in undertaking a physical/virtual hybrid every three years or so. If appropriate at the time, we will consider holding a physical AGM in 2025.
The notice of AGM for 2024 is on pages 93 to 109 and will also be available on the Company's website. Detailed explanations on the formal business and the resolutions to be proposed at the AGM are contained within the Shareholder Information section of the Annual Report and Accounts as well as the Notice of AGM.
We continue to keep abreast of ESG developments and the Board assumes a supervisory role in this regard. The Manager is responsible for considering ESG factors in the investment process.
We are led to believe that Nvidia sourced 76% of its energy from renewable sources in FY24, with a commitment to reaching 100%.
Microsoft has committed to become carbon negative, water positive and zero waste by 2030 and has a target to halve its Scope 3 emissions from 2020 to 2030.
The sources for these commitments can be found at:
https://images.nvidia.com/aem-dam/Solutions/documents/FY2024-NVIDIA-Corporate-Sustainability-Report.pdf
https://query.prod.cms.rt.microsoft.com/cms/api/am/binary/RW1lMjE
We welcome these initiatives.
The portfolio does not contain any stocks in the following sectors:
As at 31 July 2024, the portfolio has a Sustainalytics Environment score of 81.8% (where 50% is the median).
We look forward with excitement as the Era of Artificial Intelligence develops. This technology is so powerful it is quite possible that its growth can continue to overpower a challenging economic and political backdrop. However, we are of the view that the geopolitical risks that lie ahead and the stress to global networks should not be under-estimated.
Daniel Wright Chairman
25 September 2024
* Source: Bloomberg. See Glossary on pages 90 to 92.
H2 2023 and H1 2024 witnessed generally disinflationary data, lower energy prices, and better-than-expected company earnings which provided Equity Markets with further relief. Tech-heavy indices moved higher as the optimists, and also finally the pessimists, saw a forthcoming reduction in rates.
2023/4 saw an ugly unwinding of the performance of Software stocks (to which we were underweight) as expenditure was seen to be redirected to Ai.
As we have written many times in the last year, we had shifted out of "Soft Tech" names into "Hard Tech" names and repositioned with Ai "Core & Central" to our portfolio.
As we have written in earlier Newsletters, we see the Era of Ai developing in four Stages being:
2023/24 was very much a period that saw growth focused within Stages 1 & 2.
The portfolio's NAV total return per Share of 55.4% represented a 41.6% outperformance against the benchmark and compared to a 23.9% return for the Nasdaq Composite (in GBP) and a 21.4% return for the Nasdaq 100 Technology subindex (in GBP).
The 0.2% increase in the value of Sterling against the US Dollar over the year was a minor headwind for performance due to the significant level of US Dollar exposure in the portfolio. Overall, we estimate that the loss in portfolio performance from Foreign Exchange was roughly 0.1%.
The Total Return of the portfolio broken down by sector holdings in local currency (separating costs and foreign exchange) is shown below:
Total return of underlying sector holdings in local currency
| (excluding costs and foreign exchange) | 2024 |
|---|---|
| Information Technology | 55.6% |
| Communication Services | 1.4% |
| Consumer Discretionary | 0.1% |
| Other Investments (including Funds, ETFs and Hedges) | (0.1%) |
| Foreign Exchange, operating costs & financing | (1.5%) |
| Total NAV per Share return | 55.4% |
| Total return of underlying sector holdings in local currency (excluding costs and foreign exchange) |
2023 |
|---|---|
| Information Technology | 28.7% |
| Communication Services | (3.2%) |
| Consumer Discretionary | (3.3%) |
| Other Investments (including Funds, ETFs and Hedges) | (0.5%) |
| Foreign Exchange, operating costs & financing | (6.3%) |
| Total NAV per Share return | 15.3% |
The Information Technology sector delivered 100.4% of the NAV total return per Share.
Material positive performers (>1% contribution to return) included Nvidia Corp, Microsoft Corp, Arista Networks Inc, Advanced Micro Devices Inc, ASML Holding NV, Synopsys Inc and Cadence Designs Systems Inc.
There were no material negative contributors.
The portfolio's weighting to this sector (including options on a MTM basis) at the year end was 103.2% of the net assets (2023: 97.3%).
The Communication Services sector delivered 2.5% of the NAV total return per share.
Material positive performers (>1% contribution to return) included Alphabet Inc.
There were no material negative contributors.
The portfolio's weighting to this sector (including options on a MTM basis) at year end was 4.0% of the net assets (2023: 5.1%).
The Consumer discretionary sector delivered 0.2% of the NAV total return per share.
There were no material negative nor material positive contributors.
The portfolio's weighting to this sector (including options on a MTM basis) at year end was 0.0% of the net assets (2023: 0.3%). Should this weighting remain materially the same by next year end, we are likely to show exposure to the Healthcare sector instead next year.
Other holdings delivered minus 0.2% of the NAV total return per Share.
There were no material negative nor material positive contributors.
The portfolio's weighting to this sector (including options on a MTM basis) at year end was 2.8% of the net assets (2023: 7.0%).
After more than 525bps of US rate hikes over the past couple of years, the range of potential outcomes for the next 12 months now appears somewhat narrower. Advanced economies are expected to experience slower growth, inflation is expected to stay reasonably muted, and interest rate cuts are hoped to be forthcoming which when combined provide optimism for future stock returns. China remains a global deflation engine. We see geopolitical risks remaining between the US and China and continuing de-risking of supply chains.
We do believe that our portfolio of long duration assets may be more interest rate sensitive than it is sensitive to a mild recession. We also believe that if rates fall beyond a certain point (such as 2.75% – 3.00%) we could see investors switch Money Market Fund holdings for Growth Equities. We have also discussed this Fund Flow tsunami in our Newsletters throughout the year.
"It has become appallingly obvious that our technology will exceed our humanity".
– Albert Einstein
The primary challenges to equities remain inflation, recession, regulation, energy prices and war. The Fed's preferred measure, the PCE price index, has fallen but history has seen reversals before. We are hopeful that over time productivity gains from Ai can assist in further reducing inflation. There is the possibility that countries that undertake material Ai investment such as the USA, will be rewarded with a decade or so of both productivity gains and relatively strong economic growth. Should that scenario be combined with contained geopolitical risks, then we could see a period of sustained stock market returns.
In the shorter term, recession risk is always a concern when the Fed has been so active in attempting to slow the economy. Geopolitical risks, such as the conflict in Ukraine and US-Sino relations, also pose very material concerns. China, Iran, N Korea and Russia are all bad actors that can cause numerous horrific events that could cause material downside for the markets. The companies in our portfolio have a material exposure to China and Taiwan, hence we have been active at various times during the year at laying on hedges against this risk (via EWT US and MCHI US). We are constantly watching the oil price with anxiety.
"Humans are allergic to change. They love to say, 'We've always done it this way.' I try to fight that. That's why I have a clock on my wall that runs counter-clockwise." – Grace Hopper
IT spending is expected to increase by ~4% over the next 12 months. By 2028, the value of Ai accelerators used in servers may be more than \$32.8 billion, up from \$14 billion in 2023, growing at a CAGR of 18.5% according to Gartner. The Nasdaq composite is projected to deliver above-market growth in 2025 with projected revenues and earnings progress of 10.7% and 17.7% respectively. Our portfolio holdings are forecast by Bloomberg estimates to see weighted average projected revenues and earnings progress of ~25.3% and 50.9% respectively for their next financial year. Forecasts are mainly useless apart from providing some relative indications, hence the figures provided purely illustrate that our portfolio could be considered relatively faster growth. Technology stocks have seen their valuations more than recover but a lot of the overhyped stocks from 2021/22 are a long way from fully recovered in terms of valuations. We see a lot of these names ultimately being disrupted by Ai and hence they look expensive "Value Traps" to us.
"I do not fear computers. I fear the lack of them." – Isaac Asimov
We see continued spending by enterprises on digital transformation and cybersecurity, but we guess that the outliers for the next 12 months may continue to be Ai and Cloud Computing. The progress of Ai is embryonic compared to its immense, era-defining potential. As we have said many times before, we are investing in the "picks and shovels ENABLERs of Ai" and especially the hyper-scalers and the semiconductor designers. The latter is forecast to capture up to 50% of Ai's associated value and we would guess that Nvidia will get the lion's share of that. We have positioned our portfolio so that a vast majority of our holdings have Ai "core and central" to their business purpose. If Ai is the era defining technology we believe it to be, the portfolio may perform very well and, vice versa.
"The only constant is change, continuing change, inevitable change, that is the dominant factor in society today. No sensible decision can be made any longer without taking into account not only the world as it is, but the world as it will be."
– Isaac Asimov
Regulatory challenges and misinformed Luddite braying will continue, mainly dressed up as ethical concerns, but we expect that Ai's transformative capabilities overpower these headwinds.
We have also repeatedly stated in our Newsletters that we see Quantum Computing as the next era of technological advancement after Ai.
Multiple more general risks exist for our medium-term constructive view on technology. For example, we may have misunderstood how many incumbent Software and Technology companies that Ai will disrupt and we certainly feel some other investors are underestimating this risk. There may be a new technological change that we have not foreseen such as the arrival of Quantum Computing sooner than expected. China may surpass the USA in technological advancement rendering the US technology companies as disrupted. Valuations are also always a concern in Technology investing. However, contrary to the proclamations of the Bubble Callers (nearly all of whom missed the recent Ai Enablers' stock gains), we do not see the stocks in our portfolio as overvalued.
Regulation remains a key risk and as Europe falls further and further behind in the Ai era then regulation becomes perversely more likely there. The disrupted and the establishment will fight very hard to maintain the status quo. Developing US-Sino relations will continue to negatively impact supply chains, especially in semiconductors, and Taiwan's role as the leading semiconductor producer coupled with China's territorial ambitions adds a huge risk to world peace.
"A new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die, and a new generation grows up that is familiar with it." – Max Planck.
We always seek as diversified a portfolio as we can possibly construct but we must address the concentration risk within our portfolio. Our top two holdings – Microsoft, and Nvidia – represented around 59% of our NAV at the period end and our top 5 holdings represent about 78% of our portfolio. Sadly, we do believe the outstanding winners from the Ai era may in time be counted on the fingers of two hands. So what are we meant to do: diversify to dilute performance? Punish our winners for proving they are elite? The logical conclusion to this risk for shareholders that are Retail Investors is that our Fund should form part of a diversified portfolio. Please do not over-concentrate on our Fund if you cannot afford to bear potential loss. However, it is worth noting that according to two of the leading ratings agencies MSFT has a better credit rating than US sovereign debt.
May I remind you that the limits on portfolio concentration per our Investment Policy are as follows:
"No single holding will represent more than 20% of gross assets at the time of investment. In addition, the Company's five largest holdings (by value) will not exceed (at the time of investment) more than 75% of gross assets."
We do prioritize risk reduction in our approach, aiming to partially hedge specific risks that concern us (but hedging requires luck in its timing) and, in addition, avoiding any holdings that give us nagging doubts.
"Three-quarters of Warren Buffett's equity portfolio are tied up in just 5 stocks." – CNBC headline August 2023.
The risks are varied, numerous and material but the Era of Ai is in its youth. Ai offers investors a first-class ticket to what could be one of the most exciting investment and economic periods of the century.
Long the Future.
Manager
25 September 2024
Equity exposures (longs) As at 31 July 2024
| Company | Sector* | Exposure £'000** |
% of net assets** |
|---|---|---|---|
| NVIDIA Corporation** | Information Technology | 113,863 | 34.1 |
| Microsoft Corporation** | Information Technology | 83,127 | 24.9 |
| ASML Holding NV** | Information Technology | 24,221 | 7.2 |
| Advanced Micro Devices Inc. | Information Technology | 22,499 | 6.7 |
| Arista Networks Inc. | Information Technology | 21,721 | 6.5 |
| Synopsys Inc. | Information Technology | 19,366 | 5.8 |
| Broadcom Inc. | Information Technology | 16,452 | 4.9 |
| Alphabet Inc. | Communication Services |
13,643 | 4.1 |
| Micron Technology Inc. | Information Technology | 12,980 | 3.9 |
| Oracle Corporation | Information Technology | 9,967 | 3.0 |
| Cadence Design Systems Inc. | Information Technology | 8,023 | 2.4 |
| Intuitive Surgical Inc. | Health Care | 6,127 | 1.8 |
| iShares 0-3 Month Treasury Bond ETF | ETF | 5,858 | 1.7 |
| Dell Technologies Inc. | Information Technology | 4,585 | 1.4 |
| Motorola Solutions Inc. | Information Technology | 4,317 | 1.3 |
| Applied Materials Inc. | Information Technology | 3,222 | 1.0 |
| Western Digital Corporation | Information Technology | 2,281 | 0.7 |
| Polar Capital Technology Trust | Fund | 2,187 | 0.7 |
| MS AI Power Basket** | Equity Basket | 361 | 0.1 |
| Novo Nordisk A/S | Health Care | 174 | 0.1 |
| Allianz Technology Trust PLC | Fund | 10 | 0.0 |
| Total long positions | 374,984 | 112.3 | |
| Other net assets and liabilities | (40,885) | (12.3) | |
| Net assets | 334,099 | 100.0 | |
* GICS – Global Industry Classification Standard.
** Including equity swap exposures as detailed in note 13.
Portfolio sector analysis (excluding options and short equity swap hedges) As at 31 July 2024
| Sector | % of net assets |
|---|---|
| Information Technology | 103.8 |
| Communication services | 4.1 |
| Equity Basket | 0.1 |
| Fund | 0.7 |
| Health Care | 1.9 |
| ETF | 1.7 |
| Cash and other net assets and liabilities | (12.3) |
| Net assets | 100.0 |
The positions described below have an Exposure that aggregates to 99.2% of Net Assets.
Microsoft is a global enterprise software company and a leader in cloud computing, business software, operating systems and gaming.
NVIDIA is the market leader in GPUs. Whilst originally created for graphics processing, specialised GPUs are also key in the training and inference of AI models due to their parallel processing capabilities. Following the emergence of Chat GPT, which demonstrated the immense potential of generative AI, NVIDIA has reported surging demand for its AI chips. NVIDIA currently has a dominant position in the AI chip hardware market and has also built a strong position in the wider software ecosystem for AI training and inference (for example with their CUDA platform). As a result, NVIDIA has become the preferred partner for many enterprises seeking to harness the potential of AI.
ASML is a producer of Semiconductor manufacturing equipment, with a near monopoly in advanced EUV lithography, which is one of the leading edge production technologies in the industry's never ending quest to make smaller and more advanced Semiconductor chips (Integrated Circuits used in a wide variety of electronic devices).
AMD is a semiconductor company that designs and manufactures a range of microprocessors, graphics processing units (GPUs), and related technologies. Established in 1969, AMD has played a crucial role in the evolution of computing hardware, providing innovative solutions for both consumer and enterprise markets. Like NVIDIA, AMD has leveraged its GPU technology to make notable strides in the field of AI chips and accelerators. AMD's entrance into the AI chip market presents a competitive alternative to industry leader NVIDIA going forward, offering customers more options when selecting hardware for their AI workloads.
Synopsys is an EDA (electronic design automation) company that focuses on Semiconductor chip design software and verification tools (such as finding and resolving bugs in Semiconductor chip designs). EDA software is mission critical to Semiconductor chip design, particularly as the demands on Semiconductor chip capabilities continues to increase. The majority of the EDA market is controlled by three players; Cadence, Synopsys and Siemens.
Unlike the highly cyclical Semiconductor manufacturers, the EDA software market has a very high degree of recurring revenue and growth tends to be more correlated to Semiconductor R&D than Capital or Operational Expenditure within the industry.
Arista is a technology company that specialises in providing networking solutions for data centres and cloud environments. The company's products encompass a range of switches, routers, and software-defined networking (SDN) solutions, designed to meet the demands of modern data-intensive applications and the dynamic requirements of cloud computing. Arista's solutions often emphasise low-latency, high-speed data transmission, making it a key player in the networking industry, particularly for enterprises seeking advanced infrastructure solutions. As a result, Arista is heavily exposed to cloud capex from the hyperscale cloud providers.
Alphabet is a global technology company with products and platforms across a wide range of technology verticals, including online advertising, cloud computing, autonomous vehicles, artificial intelligence and smart phones.
Oracle Corporation is a multinational technology company that specialises in providing a wide range of software, hardware, and cloud-based services to businesses and organisations. Founded in 1977, Oracle is best known for its robust database management systems, which are widely used to store, retrieve, and manage large volumes of structured and unstructured data. The company's extensive portfolio includes enterprise software applications for various functions like customer relationship management (CRM), enterprise resource planning (ERP), human capital management (HCM), and more. Oracle also offers cloud services that encompass infrastructure as a service (IaaS), platform as a service (PaaS), and software as a service (SaaS), enabling clients to leverage cloud computing for enhanced scalability, efficiency, and flexibility. With a significant presence in both hardware and software markets, Oracle plays a critical role in supporting modern business operations and digital transformation efforts across industries.
Micron Technology is a leading global manufacturer of memory and storage solutions, including DRAM, NAND flash memory, and other semiconductor components. These products are critical for a wide range of computing devices, from smartphones and PCs to data centers and cloud infrastructure. As artificial intelligence (AI) continues to advance, the demand for high-performance memory is growing rapidly. AI applications, such as machine learning and deep learning, require vast amounts of data to be processed and analysed quickly. This drives the need for more memory capacity and faster data access speeds, making Micron's memory solutions increasingly vital in supporting AI workloads.
Broadcom is a global technology leader known for designing and manufacturing a wide range of semiconductor and infrastructure software products. One of Broadcom's key areas of growth is its AI ASIC (Application-Specific Integrated Circuit) business. These AI ASICs are custom-designed chips optimised for specific AI workloads, enabling faster and more efficient processing of complex algorithms used in machine learning, data analytics, and AI-driven applications. Broadcom's AI ASICs are critical in powering high-performance data centers and cloud environments, where the demand for specialised hardware to support AI workloads is rapidly increasing.
| Stocks | Gross (Underlying Only) % of NAV |
Net Delta (inc Net Delta exposure of options) % of NAV |
|---|---|---|
| NVIDIA Corporation | 34.1 | 33.8 |
| Microsoft Corporation | 24.9 | 24.9 |
| Advanced Micro Devices Inc. | 6.7 | 6.8 |
| ASML Holding NV | 7.2 | 6.8 |
| Arista Networks Inc. | 6.5 | 6.1 |
| Synopsys Inc. | 5.8 | 5.3 |
| Broadcom Inc. | 4.9 | 5.1 |
| Alphabet Inc. | 4.1 | 4.1 |
| Micron Technology Inc. | 3.9 | 4.0 |
| Oracle Corporation | 3.0 | 2.4 |
| Cadence Design Systems Inc. | 2.4 | 2.3 |
| Intuitive Surgical Inc. | 1.8 | 1.8 |
| iShares 0-3 Month Treasury Bo | 1.7 | 1.7 |
| Dell Technologies Inc. | 1.4 | 1.4 |
| Motorola Solutions Inc. | 1.3 | 1.3 |
| Applied Materials Inc. | 1.0 | 1.0 |
| Polar Capital Technology Trust | 0.7 | 0.7 |
| Western Digital Corporation | 0.7 | 0.7 |
| Remy Cointreau SA | – | 0.3 |
| Pernod Ricard SA | – | 0.1 |
| MSXXAIPW | 0.1 | 0.1 |
| Novo Nordisk A/S | 0.1 | 0.1 |
| Liberty Media Corp-Liberty Formula One | – | 0.1 |
| Allianz Technology Trust PLC | 0.0 | 0.0 |
| iShares Biotechnology ETF | – | (0.4) |
| Invesco QQQ Trust Series 1 | (0.8) | (0.8) |
| iShares Russell 2000 ETF | (0.8) | (0.8) |
| Total | 110.7 | 108.8 |
For an explanation of why we report exposures on a Delta Adjusted basis please read our FAQ at https://mlcapman.com/faq/
| Investment record of the last ten years | |||||
|---|---|---|---|---|---|
| Total | Return per | Dividend per | Net | NAV | |
| return | Share* | Share | assets | per Share* | |
| Year ended | (£'000) | (p) | (p) | (£'000) | (p) |
| 31 July 2015 | 2,483 | 11.47 | 6.00 | 63,074 | 293.35 |
| 31 July 2016 | 13,424 | 62.50 | 13.36 | 75,546 | 350.81 |
| 31 July 2017 | 20,055 | 92.43 | 9.00 | 94,661 | 429.05 |
| 31 July 2018 | 26,792 | 115.27 | 12.00 | 130,388 | 532.81 |
| 31 July 2019 | 15,900 | 58.75 | 14.00 | 166,981 | 568.66 |
| 31 July 2020 | 24,037 | 74.74 | 14.00 | 225,933 | 625.23 |
| 31 July 2021 | 22,222 | 57.10 | 14.00 | 269,686 | 665.43 |
| 31 July 2022 | (61,162) | (151.62) | 21.00 | 198,546 | 493.04 |
| 31 July 2023 | 28,754 | 71.45 | 14.00 | 221,379 | 550.79 |
| 31 July 2024 | 121,160 | 301.45 | 21.00 | 334,099 | 831.24 |

Dividends to 31 July

NAV NAV per Share
The Company is an investment company as defined by Section 833 of the Companies Act 2006 and operates as an investment trust in accordance with Section 1158 of the Corporation Tax Act 2010.
The Company is also governed by the Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority (the "FCA") and is listed on the Closed-ended investment funds Category of the London Stock Exchange.
A review of investment activities for the year ended 31 July 2024 is detailed in the Manager's review on pages 6 to 10.
The investment objective of the Company is to achieve capital appreciation.
The Company's investment objective is sought to be achieved through a policy of actively investing in a diversified portfolio, comprising any of global equities and/or fixed interest securities and/or derivatives.
The Company may invest in derivatives, money market instruments, currency instruments, contracts for differences ("CFDs"), futures, forwards and options for the purposes of (i) holding investments and (ii) hedging positions against movements in, for example, equity markets, currencies and interest rates.
The Company seeks investment exposure to companies whose shares are listed, quoted or admitted to trading. However, it may invest up to 10% of gross assets (at the time of investment) in the equities and/or fixed interest securities of companies whose shares are not listed, quoted or admitted to trading.
The Company intends to maintain a diversified portfolio and it is expected that the portfolio will have between approximately 20 to 100 holdings. No single holding will represent more than 20% of gross assets at the time of investment. In addition, the Company's five largest holdings (by value) will not exceed (at the time of investment) more than 75% of gross assets.
Although there are no restrictions on the constituents of the Company's portfolio by geography, industry sector or asset class, it is intended that the Company will hold investments across a number of geographies and industry sectors. During periods in which changes in economic, political or market conditions or other factors so warrant, the Manager may reduce the Company's exposure to one or more asset classes and increase the Company's position in cash and/or money market instruments.
The Company will not invest more than 15% of its total assets in other listed closedended investment funds. However, the Company may invest up to 50% of gross assets (at the time of investment) in an investment company subsidiary, subject always to the other restrictions set out in this investment policy and the Listing Rules.
The Company may borrow to gear the Company's returns when the Manager believes it is in Shareholders' interests to do so. The Company's Articles of Association ("Articles") restrict the level of borrowings that the Company may incur up to a sum equal to two times the net asset value of the Company as shown by the then latest audited balance sheet of the Company.
The effect of gearing may be achieved without borrowing by investing in a range of different types of investments including derivatives. Save with the approval of Shareholders, the Company will not enter into any investments which have the effect of increasing the Company's net gearing beyond the limit on borrowings stated in the Articles.
In addition to the above, the Company will observe the investment restrictions imposed from time to time by the Listing Rules which are applicable to investment companies with shares listed on the Official List of the FCA.
No material change will be made to the investment policy without the approval of Shareholders by ordinary resolution.
In the event of any breach of the investment restrictions applicable to the Company, Shareholders will be informed of the remedial actions to be taken by the Board and the Manager by an announcement issued through a regulatory information service approved by the FCA.
The fund's portfolio is constructed with flexibility but is primarily focused on stocks that exhibit the attributes of growth.
The Company was originally set up by Brian Sheppard as a vehicle for British retail investors to invest in with the hope that total returns would exceed the total returns on the UK equity market. Hence, the benchmark the Company uses to assess performance is one of the many available UK equity indices being the MSCI UK Investable Market Index (MXGBIM). The Company has used this benchmark to assess performance for over five years but is not set on using this particular UK Equity index forever into the future and currently uses this particular UK Equity index because at the current time it is viewed as the most cost advantageous of the currently available UK Equity indices (which have a high degree of correlation and hence substitutability). However, once the Company announces the use of an index, then this index should be used across all of the Company's documentation.
Investments for the portfolio are not selected from constituents of this index and hence the investment remit is in no way constrained by the index, although the Manager's management fee is varied depending on performance against the benchmark. It is suggested that Shareholders review the Company's Active Share Ratio that is on the fund factsheets as this illustrates to what degree the holdings in the portfolio vary from the underlying benchmark.
The Company considers that it does not fall within the scope of the Modern Slavery Act 2015 and it is not, therefore, obliged to make a slavery and human trafficking statement. In any event, the Company considers its supply chains to be of low risk as its suppliers are typically professional advisers.
In its oversight of the Manager and the Company's other service providers, the Board seeks assurances that they have regard to the benefits of diversity and promote these within their respective organisations. The Company has given discretionary voting powers to the Manager. The Manager votes against resolutions they consider may damage Shareholders' rights or economic interests and reports their actions to the Board. The Company believes it is in the Shareholders' interests to consider environmental, social, community and governance factors when selecting and retaining investments and has asked the Manager to take these issues into account. The Manager does not exclude companies from their investment universe purely on the grounds of these factors but adopts a positive approach towards companies which promote these factors. The portfolio's Sustainalytic's Environmental Percentile was 81.8% as at 31 July 2024.
The Company notes the Task Force on Climate-related Financial Disclosures ('TCFD') reporting recommendations. However, as a listed investment company, the Company is not subject to the Listing Rule requirement to report against the framework. The Company fully recognises the impact climate change has on the environment and society, and information on the Manager's endeavours on ESG can be found on page 4. The Manager continues to work with the investee companies to raise awareness on climate change risks, carbon emission and energy efficiency.
The Company's s172 Statement can be found in the Corporate Governance Statement on pages 43 and 44 and is incorporated into this Strategic Report by reference.
The Company may declare dividends as justified by funds available for distribution. The Company will not retain in respect of any accounting period an amount which is greater than 15% of net revenue in that period.
Recurring income from dividends on underlying holdings is paid out as ordinary dividends.
The results for the year are set out in the Statement of Comprehensive Income on page 68 and in the Statement of Changes in Equity on page 69.
For the year ended 31 July 2024, the net revenue return attributable to Shareholders was £570,000 (2023: £1,479,000) and the net capital return attributable to Shareholders was £120,590,000 (2023: £27,275,000). Total Shareholders' funds increased by 50.9% to £334,099,000 (2023: £221,379,000).
The dividends paid/proposed by the Board for 2023 and 2024 are set out below:
| Year ended 31 July 2024 |
Year ended 31 July 2023 |
|
|---|---|---|
| (pence per Share) |
(pence per Share) |
|
| Interim dividend | 7.00 | 7.00 |
| Special dividend | 7.00 | – |
| Proposed final dividend | 7.00 | 7.00 |
| 21.00 | 14.00 |
Subject to the approval of Shareholders at the forthcoming AGM, the proposed final ordinary dividend will be payable on 8 November 2024 to Shareholders on the register at the close of business on 4 October 2024. The ex-dividend date will be 3 October 2024.
Further details of the dividends paid in respect of the years ended 31 July 2024 and 31 July 2023 are set out in note 7 on page 80.
The Board considers that the following are the principal risks and uncertainties facing the Company. The actions taken to manage each of these are set out below. If one or more of these risks materialised, it could potentially have a significant impact upon the Company's ability to achieve its investment objective. These risks are formalised within the risk matrix maintained by the Company's Manager.
| Risk | How the risk is managed |
|---|---|
| Investment Performance Risk The performance of the |
Investment performance is monitored and reviewed daily by M&L Capital Management Limited ("MLCM") as AIFM through: |
| Company may not be in line with its investment |
• Intra-day portfolio statistics; and |
| objectives. | • Daily Risk reports. |
| The metrics and statistics within these reports may be used (in combination with other factors) to help inform investment decisions. |
|
| The AIFM also provides the Board with monthly performance updates, key portfolio stats (including performance attribution, valuation metrics, VaR and liquidity analysis) and performance charts of top portfolio holdings. |
|
| It should be noted that none of the above steps guarantee that Company performance will meet its stated objectives. |
|
| Key Man Risk and Reputational Risk The Company may be unable to fulfil its investment objectives following the departure of key staff at the Manager. |
The Manager has a remuneration policy that incentivises key staff to take a long-term view as variable rewards are spread over a five-year period. MLCM also has documented policies and procedures, including a business continuity plan, to ensure continuity of operations in the unlikely event of a departure. |
| MLCM has a comprehensive compliance framework to ensure strict adherence to relevant governance rules and requirements. |
|
| Fund Valuation Risk The Company's valuation is not accurately represented to investors. |
NAVs are produced independently by the Administrator, based on the Company's valuation policy. |
| Valuation is overseen and reviewed by the AIFM's valuation committee which reconciles and checks NAV reports prior to publication. |
|
| It should be noted that the vast majority of the portfolio consists of quoted equities, whose prices are provided by independent market sources; hence material input into the valuation process is rarely required from the valuation committee. |
| Risk | How the risk is managed |
|---|---|
| Third-Party Service Providers Failure of outsourced service providers in performing their contractual duties. |
All outsourced relationships are subject to an extensive dual-directional due diligence process and to ongoing monitoring. Where possible, the Company appoints a diversified pool of outsourced providers to ensure continuity of operations should a service provider fail. |
| The cyber security of third-party service providers is a key risk that is monitored on an ongoing basis. The safe custody of the Company's assets may be compromised through control failures by the Depositary or Custodian, including cyber security incidents. To mitigate this risk, the AIFM receives monthly reports from the Depositary confirming safe custody of the Company's assets held by the Custodian. |
|
| Regulatory Risk A breach of regulatory rules/ other legislation resulting in the Company not meeting its objectives or investors' loss. |
The AIFM adopts a series of pre-trade and post-trade controls to minimise breaches. MLCM uses a fully integrated order management system, electronic execution system, portfolio management system and risk system developed by Bloomberg. These systems include automated compliance checks, both pre and post-execution, in addition to manual checks by the investment team. The AIFM undertakes ongoing compliance monitoring of the portfolio through a system of daily reporting. |
| Furthermore, there is additional oversight from the Depositary, which ensures that there are three distinct layers of independent monitoring. |
|
| Fiduciary Risk The Company may not be managed to the agreed guidelines. |
The Company has a clear documented investment policy and risk profile. The AIFM employs various controls and monitoring processes to ensure guidelines are adhered to (including pre- and post execution checks as mentioned above and monthly Risk meetings). Additional oversight is also provided by the Company's Depositary. |
| Fraud Risk Fraudulent actions may cause loss. |
The AIFM has extensive fraud prevention controls and adopts a zero tolerance approach towards fraudulent behaviour and breaches of protocol surrounding fraud prevention. The transfer of cash or securities involve the use of dual authorisation and two-factor authentication to ensure fraud prevention, such that only authorised personnel are able to access the core systems and submit transfers. The Administrator has access to core systems to ensure complete oversight of all transactions. |
| Risk | How the risk is managed | |
|---|---|---|
| Portfolio Concentration The Portfolio's concentration in Nvidia Corp. and Microsoft Corp. could lead to materially negative performance results for the Company should one or both of these holdings have declining share prices. |
It is interesting to note that using a sequential selection screen of all equities on Bloomberg using the hurdles of ROIC, ROE, Operating Margin and Revenue Growth set at the rates Nvidia currently enjoys, outputs zero further suggested stocks that are domiciled outside China. |
|
| Whilst some may like us to diversify our Portfolio more, this analysis may suggest diversification would lead to the dilution of the Portfolio's average financial metrics quality. |
||
| The Manager has a series of alerts set on all Holdings which alert them to all news on Top Holdings. The Manager watches our larger holdings very carefully and has visited Nvidia in California in each of the last 3 financial years. |
||
| In addition, at times the Manager will attempt to directly hedge out some of the risk of a fall in Technology stocks by selling Call options on individual holdings. For example, at the year end, we held a Nvidia Sold Call option position. At times, we also buy Long Put options on Technology indices or individual stock names. However, these hedges are most likely to only provide immaterial comfort should large positions or the general markets decline. |
||
| Again, we encourage investors to diversify their own portfolios and only hold shares in Manchester & London as part of a well-diversified portfolio. |
In addition to the above, the Board considers the following to be the principal financial risks associated with investing in the Company: market risk, interest rate risk, liquidity risk, currency rate risk and credit and counterparty risk. An explanation of these risks and how they are managed along with the Company's capital management policies are contained in note 16 of the Financial Statements on pages 85 to 89.
The Board, through the Audit Committee, has undertaken a robust assessment and review of all the risks stated above and in note 16 of the Financial Statements, together with a review of any emerging or new risks which may have arisen during the year, including those that would threaten the Company's business model, future performance, solvency or liquidity. Whilst reviewing the principal risks and uncertainties, the Board considered the impact of the COVID-19 pandemic and the implications of the Russia conflict on the Company, concluding that these events did not materially affect the operations of the business.
In accordance with guidance issued to directors of listed companies, the Directors confirm that they have carried out a review of the effectiveness of the systems of internal financial control during the year ended 31 July 2024, as set out on pages 41 and 42. There were no matters arising from this review that required further investigation and no significant failings or weaknesses were identified.
Further discussion about risk considerations can be found in the Company's latest prospectus available at https://mlcapman.com/manchester-london-investmenttrust-plc/
At the year end, gross long equity exposure represented 112.3% (2023: 112.4%) of net assets.
The Board considers the most important key performance indicator to be the comparison with its benchmark index. This is referred to in the Financial Summary on page 3.
Other key measures by which the Board judges the success of the Company are the Share price, the NAV per Share and the ongoing charges measure.
Total net assets at 31 July 2024 amounted to £334,099,000 compared with £221,379,000 at 31 July 2023, an increase of 50.9%, whilst the fully diluted NAV per Share increased to 831.24p from 550.79p. During the year, no Ordinary Shares were bought back and held in treasury.
Net revenue return after taxation for the year was a positive £570,000 (2023: positive £1,479,000).
The quoted Share price during the period under review has ranged from a discount of 9.08% to 24.65%.
Ongoing charges, which are set out on page 3, are a measure of the total expenses (including those charged to capital) expressed as a percentage of the average net assets over the year. The Board regularly reviews the ongoing charges measure and monitors Company expenses.
The Board and the Manager do not currently foresee any material changes to the business of the Company in the near future. As the majority of the Company's equity investments are denominated in US Dollar, any currency volatility may have an impact (either positive or negative) on the Company's NAV per Share, which is denominated in Sterling.
Under the terms of the management agreement, MLCM manages the Company's portfolio in accordance with the investment policy determined by the Board. The management agreement has a termination period of three months. In line with the management agreement, the Manager receives a variable portfolio management fee. Details of the fee arrangements and the fees paid to the Manager during the year are disclosed in note 3 to the Financial Statements.
The Manager is authorised and regulated by the FCA.
M&M Investment Company Limited ("MMIC"), which is controlled by Mr Mark Sheppard who forms part of the Manager's management team, is the controlling Shareholder of the Company. Further details regarding this are set out in the Directors' Report on page 31.
The Company permanently exceeded the sub-threshold limit under the AIFMD in 2017 and MLCM was appointed as the Company's AIFM with effect from 17 January 2018. Following their appointment as the AIFM, MLCM receives an annual risk management and valuation fee of £59,000 to undertake its duties as the AIFM in addition to the portfolio management fees set out above.
The AIFMD requires certain information to be made available to investors before they invest and requires that material changes to this information be disclosed in the Annual Report.
In the year to 31 July 2024, the total remuneration paid to the employees of the Manager was £460,000 (2023: £420,000), payable to an average employee number throughout the year of three (2023: three).
The management of MLCM is undertaken by Mr Mark Sheppard and Mr Richard Morgan, to whom a combined total of £421,000 (2023: £388,000) was paid by the Manager during the year.
The remuneration policy of the Manager is to pay fixed annual salaries, with non-guaranteed bonuses, dependent upon performance only. These bonuses are generally paid in the Company's Shares, released over a five-year period.
The leverage policy has been approved by the Company and the AIFM. The policy limits the leverage ratio that can be deployed by the Company at any one time to 275% (gross method) and 250% (commitment method). This includes any gearing created by its investment policy. This is a maximum figure as required for disclosure by the AIFMD regulation and not necessarily the amount of leverage that is actually used. The leverage ratio as at 31 July 2024 measured by the gross method was 122.4% and that measured by the commitment method was 117.5%.
Leverage is defined in the Glossary on page 91.
The risk profile of the Company as measured through the Summary Risk Indicator ("SRI") score, is currently at a 6 on a scale of 1 to 7 as at 31 July 2024 (31 July 2023: 6). This score is calculated on past performance data using prescribed PRIIPS methodology. Liquidity, counterparty and currency risks are not captured on the scale. The Manager will periodically disclose the current risk profile of the Company to investors. The Company will make this disclosure on its website at the same time as it makes its Annual Report and Financial Statements available to investors or more frequently at its discretion.
For further information on SRI – including key risk disclaimers – please read the Fund Key Information Document available at https://mlcapman.com/manchester-londoninvestment-trust-plc/
The Company currently holds no assets that are subject to special arrangements arising from their illiquid nature. If applicable, the Company would disclose the percentage of its assets subject to such arrangements on its website at the same time as it makes its Annual Report and Financial Statements available to investors, or more frequently at its discretion.
The Board keeps the performance of MLCM, in its capacity as the Company's Manager, under continual review. It has noted the good long-term performance record and commitment, quality and continuity of the team employed by the Manager. As a result, the Board concluded that it is in the best interests of the Shareholders as a whole that the appointment of the Manager on the agreed terms should continue.
The Board consists entirely of non-executive Directors. The Company has no employees and day-to-day management of the business is delegated to the Manager and other service providers. As an investment trust, the Company has no direct impact on the community or the environment, and as such has no human rights or community policies. In carrying out its investment activities and in relationships with suppliers, the Company aims to conduct itself responsibly, ethically and fairly. Further details of the Environmental, Social and Governance policy can be found in the Statement of Corporate Governance on pages 42 and 43. Details of the Company's Board composition and related diversity considerations can be found in the Statement of Corporate Governance on page 38.
At 31 July 2024, the Board comprised four male Directors. As stated in the Statement of Corporate Governance, the appointment of any new Director is made on the basis of merit.
This Strategic Report has been approved by the Board and signed on its behalf by:
Chairman
25 September 2024


All the Directors are non-executive. Mr Morris, Sir James Waterlow and Mr Wright are independent of the Company's Manager.
Mr Morris was appointed to the Board of the Company on 10 December 2021. He is the Company's Senior Independent Director ("SID"). He is currently CFO of Big Technologies PLC, a company listed on AIM and active in the provision of advanced technology for the electronic monitoring of individuals. Mr Morris was previously CFO of Volex PLC from 2015 to 2020. He was part of the executive management team that led a turnaround of Volex and drove a quadrupling of the share price over the period. He spent the first eighteen years of his career in investment banking and accountancy and was a Managing Director at both UBS Investment Bank and Morgan Stanley, advising manufacturing and technology companies on their expansion and financing strategies. Daren's public company board experience includes Big Technologies plc, Volex plc, Easynet plc and Nexen Tech Corporation. Daren is a qualified chartered accountant (ICAEW ACA 1997) and read Physics at Trinity College, Oxford.
Mr Morris is Chairman of the Audit Committee. Number of Listed Company Directorships: 2
Mr Miller was appointed to the Board on 30 August 2013. He presently also serves as a director of SLF Realisation Fund Limited and Ecofin US Renewables Infrastructure Trust Plc. In addition he is a director of a number of unlisted and/or private companies. He graduated from the University of the Witwatersrand (South Africa) with a bachelors degree majoring in law and economics and additionally holds a law degree from the London School of Economics. He qualified as a solicitor and practised until 1997. Mr Miller is head of compliance, governance and risk oversight, holds the SMF16 and SMF17 roles under the Senior Managers and Certification Regime and also sits on the risk management committee of MLCM, the Company's Manager.
Mr Miller is not a member of the Audit Committee. Number of Listed Company Directorships: 3
Sir James Waterlow was appointed to the Board on 17 August 2020. He has specialised in investment trusts for thirty years, for the past fifteen as a partner on the Investment Funds team at Singer Capital Markets. During his career he has advised approximately thirty investment trust boards and worked on a significant number of transactions, raising over £5 billion for new and existing funds.
Sir James Waterlow is a member of the Audit Committee. Number of Listed Company Directorships: 1
Mr Wright was appointed to the Board on 29 October 2018. He is the executive chairman of Science in Sport Plc, appointed in October 2023 to lead the turnaround of that business. He is a non-executive director of SolasCure Limited and non-executive chairman of Uinsure Group Holdings. Mr Wright was previously the founder partner, chief operating officer and head of portfolio at NorthEdge Capital, executive chairman of Accrol Group Holdings Plc, and Chairman of Vision Support Services Group Limited, a private company that he founded and grew to become Europe's leading distributor of textiles to the hospitality sector. He has also held previous roles at Cable Partners LLC, Deutsche Morgan Grenfell Private Equity and The Royal Bank of Scotland. Mr Wright qualified as a chartered accountant with Arthur Andersen in 1996.
Mr Wright is the Chairman of the Board. Number of Listed Company Directorships: 2
The Directors present their report and the audited Financial Statements for the year ended 31 July 2024.
The current Directors of the Company are listed on page 28. All served throughout the year under review.
Details about the re-election of the Directors are given in the Statement of Corporate Governance on page 38.
As at 31 July 2024, the Company's issued share capital comprised 40,528,238 Shares of 25 pence each, of which 335,220 were held in Treasury.
At general meetings of the Company, Shareholders are entitled to one vote on a show of hands and on a poll, to one vote for every Share held. Shares held in Treasury do not carry voting rights.
In circumstances where Chapter 11 of the Listing Rules would require a proposed transaction to be approved by Shareholders, the controlling Shareholder (see page 31 for further details) shall not vote its Shares on that resolution. In addition, any Director of the Company appointed by MMIC, the controlling Shareholder, shall not vote on any matter where conflicted and the Directors will act independently from MMIC and have due regard to their fiduciary duties.
At the Annual General Meeting held on 1 November 2023, Shareholders approved the Board's proposal to authorise the Company to allot Shares up to an aggregate nominal amount of £2,512,064. In addition, the Directors were authorised to issue Shares and sell Shares from Treasury up to an aggregate nominal value of £1,004,826 on a non-pre-emptive basis. This authority is due to expire at the Company's forthcoming AGM on 6 November 2024.
There were no share issues during the year.
As at the latest practicable date of 20 September 2024, the total voting rights were 40,127,018.
At the Annual General Meeting held on 1 November 2023, Shareholders approved the Board's proposal to authorise the Company to acquire up to 14.99% of its issued Share capital (excluding Treasury Shares) amounting to 6,024,933 Shares. This authority is due to expire at the Company's forthcoming AGM on 6 November 2024. Since September 2021, the highest price the Company has paid for shares held in Treasury was 666 pence. The average cost per share of the shares held in Treasury was 549 pence. As at 31 July 2024, the share price was 704 pence.
During the year, 0 Shares have been bought back and at 31 July 2024 there were 40,528,238 Shares in issue of which 335,220 were held in treasury. After the year end, 66,000 shares were bought back into Treasury, at an average price of 625p, increasing the number of shares held in Treasury to 401,220.
At the Annual General Meeting held on 1 November 2023, Shareholders approved the Board's proposal to authorise the Company to waive pre-emption rights in respect of Treasury Shares up to an aggregate amount of £1,004,826 and to permit the allotment or sale of Shares from Treasury at a discount to a price at or above the prevailing NAV. This authority is due to expire at the Company's forthcoming AGM on 6 November 2024.
No Shares were sold from Treasury during the year. As at the latest practicable date of 20 September 2024, 401,220 Shares are held in Treasury.
The Company has been informed of the following notifiable interests in the Company's Share capital carrying voting rights as at 31 July 2024:
| Number of Shares held |
% of total voting rights |
|
|---|---|---|
| M&M Investment Company Limited* | 23,300,866 | 57.97 |
Following the year end, the Company has been informed that there has been a change in interests as at the latest practicable date. As at the latest practicable date, the notifiable interests in the Company's Share capital is:
| Number of Shares held |
% of total voting rights |
|
|---|---|---|
| M&M Investment Company Limited* | 23,310,866 | 58.09 |
* Figures include shares held by connected parties.
MMIC, which is controlled by Mr Mark Sheppard who forms part of the investment management team at MLCM, is the controlling Shareholder of the Company.
The Company has in place a continuing written and legally binding relationship agreement with MMIC and its associates. Since entering the relationship agreement, the Company has fully complied with the independence provisions included within this agreement and, so far as the Company is aware, the independence provisions included in this agreement have also been complied with during the period under review by the controlling Shareholder and its associates. The relationship agreement is available on the Company's website.
Under the shareholder relationship agreement between the Company and MMIC, the Controlling Shareholder can appoint non-executive Directors to the Board, as long as the majority of these appointments are deemed to be independent from MMIC and the appointment of all Directors are not to the detriment of the Shareholders as a whole.
As at the latest practicable date, MMIC holds 58.09% of the total voting rights of the Company.
The following information is disclosed in accordance with the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 and DTR 7.2.6 of the FCA's Disclosure Guidance and Transparency Rules.
Details of the interim dividend and special dividend paid by the Company during the year and the final dividend recommended by the Board are set out in the Strategic Report on page 19.
There are no post balance sheet events to report.
The principal financial risks and the Company's policies for managing these risks are set out in note 16 to the Financial Statements.
The Statement of Corporate Governance on pages 35 to 44 forms part of the Directors' Report.
The Directors consider that it is appropriate to adopt the going concern basis in preparing the Financial Statements. After making enquiries, and considering the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future. In arriving at this conclusion, the Directors have considered the liquidity of the portfolio and the Company's ability to meet obligations as they fall due for a period of at least 12 months from the date that these Financial Statements were approved.
Cashflow projections have been reviewed and provide evidence that the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of the dividend policy. Additionally, Value at Risk scenario analyses to demonstrate that the company has sufficient capital headroom to withstand market volatility are performed periodically.
The Directors have assessed the prospects of the Company over a five-year period. The Directors consider five years to be a reasonable time horizon to consider the continuing viability of the Company, however they also consider viability for the longer-term foreseeable future.
In their assessment of the viability of the Company, the Directors have considered each of the Company's principal risks and uncertainties as set out in the Strategic Report on pages 20 to 22 and in particular, have considered the potential impact of a significant fall in global equity markets on the value of the Company's investment portfolio overall. The Directors have also considered the Company's income and expenditure projections and the fact that the Company's investments mainly comprise readily realisable securities which could be sold to meet funding requirements if necessary. On that basis, the Board considers that five years is an appropriate time period to assess continuing viability of the Company.
In forming their assessment of viability, the Directors have also considered:
The Board has reviewed the influence of the COVID-19 pandemic on its service providers and is satisfied with the ongoing services provided to the Company.
Based upon these considerations, the Directors have concluded that there is a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the five-year period.
The Company has no greenhouse gas emissions to report from its operations, nor does it have responsibility for any other emissions producing sources under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013, including those within its underlying portfolio. As the Company's energy consumption falls under the minimum 40,000 kWh reporting threshold set by the Streamlined Energy and Carbon Reporting framework, the Company is exempt from making energy consumption disclosures.
The Company made no political or charitable donations during the year.
Listing Rule 6.6.1 requires the Company to include specified information in a single identifiable section of the Annual Report or a cross reference table indicating where the information is set out.
The Directors confirm that no additional disclosures are required in relation to Listing Rule 6.6.1.
The Directors who held office at the date of approval of the Directors' Report confirm that, so far as they are each aware, there is no relevant audit information of which the Company's Auditor is unaware, and each Director has taken all the steps that he ought to have taken as a Director to make himself aware of any relevant audit information and to establish that the Company's Auditor is aware of that information.
The Annual General Meeting of the Company will be held virtually on Wednesday, 6 November 2024 at 12.00 noon.
The notice convening the Annual General Meeting is set out on page 93 and includes an explanation of the items of business to be considered at the meeting. This notice can also be found on the Company's website.
By order of the Board
Company Secretary
25 September 2024

This corporate governance statement forms part of the Directors' Report.
The Board is accountable to Shareholders for the governance of the Company's affairs and is committed to maintaining high standards of corporate governance and the principles of good governance as set out in the UK Corporate Governance Code (the "UK Code") issued by the Financial Reporting Council in July 2018, a copy of which can be found at www.frc.org.uk.
Pursuant to the Listing Rules of the FCA, the Company is required to provide Shareholders with a statement on how the principles set out in the UK Code have been applied and whether the Company has complied with the provisions of the UK Code. The Board recognises the importance of a strong corporate governance culture and has established a framework for corporate governance which it considers to be appropriate to the business of the Company as an investment trust.
The Board has reviewed the principles and provisions of the UK Code and considers that it has complied throughout the year, except as disclosed below:
During the year, the Company appointed Daren Morris as a SID (see page 4). This appointment fulfills Provision 12 of the UK Code, providing a sounding board for the Chairman and serving as an intermediary for the other Directors and shareholders.
Under the leadership of the Chairman, the Board is responsible for the effective stewardship of the Company's affairs, including corporate strategy, corporate governance, risk assessment and the investment policy. The Directors have overall responsibility for review of the Company's investment activity and performance and the control and supervision of the Manager and other service providers of the Company.
The Board consists of four non-executive Directors, three of whom are considered to be independent of the Company's Manager. The Board seeks to ensure that it has an appropriate balance of skills and experience and considers that, collectively, the Directors have an appropriate balance of skills, experience, independence and knowledge of the Company to enable it to provide effective strategic leadership and proper governance of the Company.
The terms and conditions of appointment of the Directors are formalised in letters of appointment, copies of which are available for inspection from the Company's registered office. None of the Directors has a contract of service with the Company nor has there been any other contract or arrangement between the Company and any Director at any time during the year.
The Board has ensured that all Directors continually update the skills and knowledge required to fulfil their role both on the Board and the Audit Committee. The Directors have access to the advice and services of the Company Secretary who is responsible to the Board for ensuring that established Board procedures and applicable rules and regulations are complied with.
The Chairman leads the Board and is responsible for its overall effectiveness in directing the Company. He promotes a culture of openness and debate and facilitates constructive Board relations and the effective contribution of all Directors. In liaison with the Company Secretary, he ensures that the Directors receive accurate, timely and clear information. The Chairman, Daniel Wright, is deemed by his fellow independent Board members to be independent and free of any conflicts of interest. He considers himself to have sufficient time to spend on the affairs of the Company. The role and responsibilities of the Chairman are clearly defined and set out in writing, copies of which are available on the Company's website.
As part of its annual evaluation, the Board reviewed the independence status of each Director and the Board as a whole. In the Board's opinion, Mr Morris, who is the Company's SID, Sir James Waterlow and Mr Wright are considered to be independent of the Manager in both character and judgement that they perform their duties at all times in an independent manner and that there are no relationships or circumstances which are likely to affect the judgement of any Director.
As set out on page 28, Mr Miller is head of governance and risk oversight, holds the SMF16 and SMF17 roles under the Senior Managers and Certification Regime and sits on the risk management committee at MLCM, the Company's Manager. Therefore, Mr Miller is not deemed to be independent of the Manager. Due to his non-independent status, Mr Miller abstains from discussions about the continuing appointment of the Manager.
Following completion of the evaluation process, the Board is of the opinion that Mr Miller continues to provide effective contributions to the performance of the Board and is committed to his role. As regards his effectiveness, Mr Miller's biographical details set out on page 28 demonstrate the experience he brings to the Board, which is complementary to that of the other Directors.
Apart from Mr Miller, none of the Directors or any persons connected with them had a material interest in the transactions and arrangements of, or the agreement with, the Manager during the year.
The Board has established a questionnaire-based process for the annual evaluation of the performance of the Board, the Audit Committee and the individual Directors, led by the Chairman. The Chairman acts on the results of the evaluation by recognising the strengths and addressing any weaknesses of the Board, as appropriate.
Following this year's evaluation, the Board is satisfied that the structure, mix of skills and operation of the Board continue to be effective and relevant for the Company, offering a balance of independence and knowledge of the Company to enable it to provide effective strategic leadership and proper governance of the Company. The performance of each of the Directors continues to be effective and demonstrates commitment to the role and having considered the Directors' other time commitments and directorships. The Board is satisfied that each Director has the capacity to be fully engaged with the Company's business.
The Board does not consider the use of external consultants to conduct this evaluation is likely to provide any meaningful advantage over the process that has been adopted. However, the option of doing so will be regularly reviewed.
The following disclosures are provided in respect of the FCA Listing Rules targets that: i) 40% of a board should be women; ii) at least one senior role should be held by a woman; and iii) at least one board member should be from a non-white ethnic background, as defined by the Office of National Statistics (ONS) criteria. As an externally managed investment company with no chief executive officer (CEO) or chief financial officer (CFO), the roles which qualify as senior under FCA guidance are Chair and Senior Independent Director (SID). The Board also considers the role of Audit Committee Chair to represent a senior role within this context. The Board has considered that the Company's year end date to be the most appropriate date for disclosure purposes. There have been no changes since 31 July 2024, data has been collected on a self-reporting basis and the Directors were asked to confirm that the data reported at 31 July 2023 remained valid and correct. As at 31 July 2024, the Board comprised four Non-Executive Directors, all men, and included two chartered accountants, one investment trust specialist and a former qualified lawyer. The Board's recruitment process seeks to draw upon as diverse a pool of candidates as possible, including men and women from across all ethnic backgrounds working in the fields of science, industry, finance and technology.
As at 31 July 2024, the Board did not comply with the FCA Listing Rule target with respect to ethnic background nor was it compliant with respect to the 40% target for women or that one senior role should be held by a woman. The Board's ongoing succession planning will take this target into consideration. If anyone reading this Annual Report believes they are a suitable candidate for a non-executive director role on this board and wishes to be considered for succession planning, please contact the Manager of the Company at [email protected] with your CV.
| Gender | Number of Board Members |
% of the Board |
Number of senior positions on the Board |
|---|---|---|---|
| Men | 4 | 100% | 2 |
| Ethnic background | Number of Board Members |
% of the Board |
Number of senior positions on the Board |
| White British or Other White (including minority white groups) |
4 | 100% | 2 |
The Board does not have a specific policy on tenure. Under the Company's Articles of Association and in accordance with the UK Code, Directors are subject to election by Shareholders at the first annual general meeting after their appointment. Thereafter, at each annual general meeting, any Director who has not stood for re-election at either of the two preceding annual general meetings shall retire and be subject to re-election. In addition, one‑third of the Directors eligible to retire by rotation shall retire from office at each annual general meeting.
Beyond these requirements, the Board has agreed a policy whereby all Directors will seek annual re‑election at the Company's annual general meetings. This is in line with the recommendations of the UK Code.
The Board has considered the re-election of Mr Wright, Mr Miller, Mr Morris and Sir James Waterlow at the forthcoming Annual General Meeting and recommends this on the basis of their skills, knowledge and continued contribution.
A procedure for the induction of new Directors has been established, including the provision of an induction pack containing relevant information about the Company, its processes and procedures. New appointees will have the opportunity of meeting with the Chairman and relevant persons at the Manager.
The Board has formalised arrangements under which Directors, in the furtherance of their duties, may take independent professional advice. Under the Company's Articles of Association, the Directors are provided, subject to UK legislation, with an indemnity in respect of liabilities which they may sustain or incur in connection with their appointment. Apart from this, there were no third party indemnity provisions over the course of the year or since the year end.
It is the responsibility of the Board to ensure that there is effective stewardship of the Company's affairs and that the Company meets its obligations to Shareholders. Strategic issues and all operational matters of a material nature are determined by the Board and, in order to enable them to discharge their responsibilities, Directors have full and timely access to relevant information. Board responsibilities include:
The Board meets regularly and at each meeting reviews investment performance and financial results and monitors compliance with the Company's objectives.
The Board and Committee agendas are shaped to ensure that discussion is focused on the Company's strategic priorities, principal activities, reviews of significant issues and key elements of the portfolio.
At each Board meeting, the Directors follow a formal agenda which is circulated in advance by the Company Secretary. The Company Secretary, Administrator and Manager regularly provide financial information, together with briefing notes and papers in relation to changes in the Company's economic and financial environment, statutory and regulatory changes and corporate governance best practice.
The Company's day-to-day functions have been subcontracted to a number of service providers, each engaged under separate legal agreements. The management of the Company's assets has been delegated to MLCM, which has discretion to manage the assets in accordance with the Company's investment policy.
At each Board meeting, a representative from the Manager is in attendance to present verbal and written reports covering the Company's activities, portfolio and investment performance over the preceding period. Ongoing communication with the Board is maintained between formal meetings.
The Directors meet at regular Board meetings, with additional meetings arranged as necessary. Board and Committee meetings held during the year 31 July 2024 and the attendance of the individual Directors are shown below:
| Board Meetings |
Audit Committee |
|
|---|---|---|
| Number of meetings during the year |
4 | 2 |
| Daniel Wright | 4/4 | 2/2 |
| Brett Miller* | 4/4 | 2/2 |
| Daren Morris | 3/4 | 2/2 |
| Sir James Waterlow | 4/4 | 2/2 |
* Mr Miller is not a member of the Audit Committee.
The Board is assisted in its operations by the Audit Committee, the terms of reference for which are available on the Company's website.
The Audit Committee comprises Mr Wright, Mr Morris and Sir James Waterlow and since his appointment on 10 December 2021 is chaired by Mr Morris. Mr Morris, a qualified chartered accountant, is deemed to have recent and relevant financial experience and the Committee as a whole has competence relevant to the investment trust sector.
A Report from the Audit Committee is set out on pages 45 to 47.
It is the responsibility of each individual Director to avoid an unauthorised conflict of interest situation arising. Directors must request authorisation from the Board as soon as they become aware of the possibility of an interest that conflicts or might possibly conflict with the interests of the Company (a "situational conflict"). The Company's Articles of Association authorise the Board to approve such situations, where deemed appropriate.
The Board is responsible for considering Directors' requests for authorisation of situational conflicts and for deciding whether or not the situational conflict should be authorised. The factors to be considered will include: whether the situational conflict could prevent the Director from properly performing his duties; whether it has, or could have, any impact on the Company; and whether it could be regarded as likely to affect the judgement and/or actions of the Director in question. When the Board is deciding whether to authorise a conflict or potential conflict, only Directors who have no interest in the matter being considered are able to take the relevant decision, and in taking the decision, the Directors must act in a way they consider, in good faith, will be most likely to promote the Company's success. The Directors are able to impose limits or conditions when giving authorisation if they think this is appropriate in the circumstances.
A register of conflicts is maintained by the Company Secretary and is reviewed at Board meetings, to ensure that any authorised conflicts remain appropriate. Directors are required to confirm at these meetings whether there has been any change to their position.
The Board is responsible for risk management and ensuring that the Company has in place an effective system of internal financial controls designed to ensure the maintenance of proper accounting records and the safeguarding of the Company's assets. These systems are designed to provide reasonable, but not absolute, assurance against material misstatement or loss. The Board recognises its responsibility for regular review of all aspects of internal financial control.
The Board has established an ongoing process for identifying, evaluating and managing the principal risks faced by the Company. This process is subject to regular review by the Board and is in accordance with the FRC Guidance on Risk Management, Internal Control and Related Finance and Business Reporting. The process was fully in place throughout the year and up to the date of approval of the Financial Statements. The principal risks facing the Company and the actions taken to manage these are detailed on pages 20 to 22.
The Board has established a series of parameters which are designed to limit the inherent risk in managing a portfolio of investments and the Board receives regular reports from the Manager and Administrator, which are reviewed in detail.
The Board has contractually delegated responsibility for management of the investment portfolio, risk management and the provision of accounting services to external service providers. This is after full and proper consideration by the Board of the quality and cost of services offered, including the financial control systems in operation insofar as they relate to the affairs of the Company.
The key procedures which have been established to provide effective internal control, are as follows:
The Board has carried out a review of the effectiveness of the risk management and internal control systems and how those systems operated throughout the year. The Directors confirm that no significant failings or weaknesses were identified.
The Company's defined purpose is to deliver its investment objective. The Directors agree that establishing and maintaining a healthy corporate culture among the Board and in its interaction with the Manager and Shareholders will support the delivery on its purpose, values and strategy. The culture of the Board promotes a desire for good governance, mindful of the interests of the Company's stakeholders. The Board believes that, as an investment trust with no employees, this is best achieved by working in partnership with the Manager.
The Company has a number of policies and procedures in place to assist with maintaining a culture of good governance such as those relating to Diversity, Directors' conflicts of interest and Directors' dealings in the Company's Shares. The Board assesses and monitors compliance with these policies as well as the general culture of the Board through Board meetings and in particular during the annual evaluation process which is undertaken by each Director (for more information see the performance evaluation section on page 37).
The Board seeks to ensure the alignment of its purpose, values and strategy with its culture through ongoing dialogue and engagement with its service providers, principally the Manager. The culture of the Company's service providers, including their policies, practices and behaviour, is considered by the Board as a whole during the annual review of the performance and continuing appointment of all service providers.
As an investment trust, the Company has adopted the environmental, social and governance policy ("ESG") of its Manager. This ESG policy can be found at the Manager's website at www.mlcapman.com/esg.
In addition, the Company's ethical policy is focused on ensuring that the Company's resources are properly managed and invested within the guidelines approved by the Board.
The Company's Manager ensures that investments are made in companies that it considers to be well managed and subject to appropriate corporate governance. A well-managed company is considered to be one which complies with all the relevant legislation and which meets the environmental, social, community and ethical requirements of the country in which it operates. It is important to recognise that local laws and requirements of some markets do not necessarily equate with those of developed countries.
The Manager performs extensive investment analysis, assessing both the risk and the return of targeted investments for the Company. The depth of its research provides comprehensive insights into the many factors that affect the value of an investment, which also include environmental, social and governance issues. This analysis is monitored by the Manager and reported to the Board.
The Company's ultimate objective is to maximise investment return for its Shareholders without bearing an unacceptable level of risk. Accordingly, the Board and the Manager will seek to favour companies that pursue best practice in governance.
Some examples of the Company's ESG policy in practice are set out below:
The Board has agreed that a formal policy regarding voting in investee companies is not required. It has given the Manager discretionary voting powers to vote how it deems appropriate whilst maintaining a primary focus on financial returns. The Manager utilised the votes of the Company on seven different occasions during the year (2023: seven).
The Directors have a duty (under section 172 of the Companies Act 2006) to promote the success of the Company for the benefit of Shareholders as a whole. In doing so, the Directors must have regard to other broader matters including the likely long-term consequences of any decision, and on the need to foster the Company's relationships with its employees, suppliers, customers and others and to have regard to their interests, the impact of the Company on the community and the environment, and the desirability of maintaining a reputation for high standards of business conduct.
The Board seeks to understand the needs and priorities of the Company's stakeholders and these are taken into account during all its discussions and as part of its decisionmaking. The Chairman ensures that the Board as a whole has a clear understanding of the views of Shareholders by receiving regular updates from the Manager.
During the year under review, the Board has continued to discuss and monitor which parties should be considered as stakeholders of the Company and has again concluded that, as the Company is an externally managed investment trust and does not have any employees or customers in the traditional sense, the Company primarily owed a duty of care to its Shareholders. Furthermore, as a Company with a majority Shareholder, safeguarding the interests of minority Shareholders was considered of particular importance. Due to the Company's relatively small size, the Board considered the impact on parties other than its Shareholders to be minimal and in line with the FRC Guidance in relation to section 172(1) statements, this statement focuses on stakeholders that are considered key to the Company's business, and therefore does not cover every stakeholder in the Company. The section below discusses the actions taken by the Company to ensure that the interests of the Shareholders are taken into account.
The Board is committed to maintaining open channels of communication and to engage with Shareholders in a manner which they find most meaningful, in order to gain an understanding of the views of Shareholders. These include:
Feedback from meetings between the Manager and Shareholders is shared with the Board. The Chairman, the Chairman of the Audit Committee or other members of the Board are available to meet with Shareholders to understand their views on governance and the Company's performance where they wish to do so.
The above mechanisms for engaging with stakeholders are kept under review by the Directors and will be discussed on a regular basis at Board meetings to ensure that they remain effective. The Board recognises the importance of engaging with its core stakeholders, and of taking account of their interests when making decisions. Should the Shareholders of the Company wish to contact the Chair of the Company, they can do so by contacting the registered office of the Company.
I am pleased to present the Audit Committee (the "Committee") report for the year ended 31 July 2024. The Composition of the Committee is set out on page 40.
The primary responsibilities of the Committee are to:
The Committee has direct access to the Auditor, who is also invited to attend the Committee meeting at which the Annual Report and Financial Statements are reviewed.
The Committee met twice during the financial year. Details of the composition of the Committee, attendance and how its performance evaluation has been conducted are detailed in the Statement of Corporate Governance on pages 35 to 44.
The Committee has:
The Audit Committee has reviewed and, where appropriate, updated the risk matrix. This is done on a six-monthly basis.
The significant issues considered by the Committee in relation to the Company's Annual Report and Financial Statements were:
Following consideration and detailed review of the above, the Committee was of the opinion that the Annual Report and Financial Statements, taken as a whole, are fair, balanced and understandable, and provide the information necessary to assess the Company's position and performance, business model and strategy, and advised the Board accordingly.
Deloitte LLP ("Deloitte") were appointed as the Company's Auditor on 28 November 2016, in relation to the audit for the year ended 31 July 2017. Their appointment was approved by Shareholders at the Annual General Meeting held on 27 November 2017.
Michael Caullay is the audit partner for 2023/2024.
In accordance with audit tender requirements, the Company, being a public interest entity, intends to carry out an audit tender during 2026 in respect of the 2027 audit.
The Committee reviewed and approved the audit plan and fees presented by the Auditor and considered its report on the Financial Statements. Details of the audit fee for the year ended 31 July 2024 are set out in note 4 to the Financial Statements.
The Committee reviews the need for non-audit services and authorises such on a case-by-case basis, giving consideration to the cost effectiveness of the services and the independence and objectivity of the Auditor, and taking into account relevant UK law, regulation, ethical standards and other professional and regulatory requirements. Non-audit work may be given to the external Auditor unless there is a conflict of interest or someone else is considered to have more relevant experience. Any non-audit work to be carried out by the Auditor, including any special projects, must be approved by the Committee in advance. No non-audit services were provided by the Auditor during the year (2023: nil).
As part of the review of the Auditor's independence and objectivity, Deloitte has confirmed that it is independent of the Company and has complied with relevant auditing and ethical standards. In evaluating Deloitte, the Committee has taken into consideration the standing, skills and experience of the firm and the audit team. The Committee, from direct observation and enquiry of the Manager, the Administrator and the Company Secretary, is satisfied that Deloitte is both independent and effective at carrying out its responsibilities. Deloitte's performance will continue to be reviewed annually taking into account all relevant governance guidance and best practice. Should the Auditor become aware of any situation that might potentially compromise its independence, the Committee expects the Auditor to bring that situation to its attention at the earliest opportunity.
The Chairman of the Committee maintains regular contact with the Auditor and the Committee has considered the performance of the Auditor, the services provided by it during the year and reviewed its independence and objectivity.
The Committee also monitors and reviews the effectiveness of the external audit process for the Annual Report, including a detailed review of the audit plan and audit results report and discussion of these with the Auditor, and makes recommendations to the Board on the appointment/re-appointment, remuneration and terms of engagement of the Auditor. Any concerns regarding the effectiveness of the external audit process would be reported to the Board. No concerns were raised in respect of the year ended 31 July 2024.
In determining whether to recommend the re-appointment of the Auditor, the Committee takes into account their effectiveness, relevant knowledge and value added service together with value for money. On the basis of this assessment, the Committee recommended to the Board to propose the re-appointment of Deloitte as Auditor to the Company at the forthcoming Annual General Meeting.
Chairman of the Audit Committee
25 September 2024
The Board has prepared this report in accordance with the requirements of the Large and Medium-Sized Companies and Groups (Accounts and Reports) (Amendment) Regulations 2013 in respect of the year ended 31 July 2024. An ordinary resolution for the approval of this Report will be put to Shareholders at the forthcoming Annual General Meeting.
The law requires the Company's Auditor to audit certain disclosures provided. Where disclosures have been audited, they are indicated as such. The Auditor's opinion is included in the Independent Auditor's Report on pages 56 to 65.
I am pleased to present the Directors' Remuneration Report for the year ended 31 July 2024.
The Board reviewed the level of remuneration payable to each Director during the year. Each Director of the Company takes no part in discussions concerning their own remuneration.
Directors' fees were changed during the year, effective from 1 April 2024. The Chairman is paid a fee of £35,000, the Audit Committee Chairman is paid a fee of £30,000, the fee paid to other independent Directors is £27,000 and the fee for non-independent Directors is £25,000.
The Directors' Remuneration Policy was approved by shareholders at the 2023 Annual General Meeting. The Board does not propose to make any changes to the existing remuneration policy. There will be no significant change in the way the remuneration policy is implemented during the course of the next financial year.
The Directors who served during the year received the following emoluments in the form of fees:
| Fees | Expenses* | Total | |||||
|---|---|---|---|---|---|---|---|
| Year to 31 July 2024 £ |
Year to 31 July 2023 £ |
Year to 31 July 2024 £ |
Year to 31 July 2023 £ |
Year to 31 July 2024 £ |
Year to 31 July 2023 £ |
||
| Daniel Wright (Chairman) |
30,333 | 28,000 | 1,168 | 1,788 | 31,501 | 29,788 | |
| Brett Miller | 21,667 | 20,000 | – | – | 21,667 | 20,000 | |
| Daren Morris | 26,667 | 25,000 | – | – | 26,667 | 25,000 | |
| Sir James Waterlow | 23,667 | 22,000 | – | – | 23,667 | 22,000 | |
| 102,334 | 95,000 | 1,168 | 1,788 | 103,502 | 96,788 |
* Travel expenses incurred in relation to attendance at Board and Committee meetings of the Company.
| Fees | Percentage change | ||||||
|---|---|---|---|---|---|---|---|
| Year to 31 July 2024 £ |
Year to 31 July 2023 £ |
2023- 2024 % |
2022- 2023 % |
2021- 2022 % |
2020- 2021 % |
2019- 2020 % |
|
| Daniel Wright (Chairman)* |
30,333 | 28,000 | 5.8 | 2.7 | 16.9 | 41.4 | 43.7 |
| Brett Miller | 21,667 | 20,000 | 8.3 | – | 1.7 | 22.9 | – |
| Daren Morris** | 26,667 | 25,000 | 6.7 | 55.1 | N/A | – | – |
| David Harris*** | – | – | – | – | (67.9) | 43.0 | 6.5 |
| Sir James Waterlow | 23,667 | 22,000 | 7.6 | – | 5.5 | N/A | – |
| 102,334 | 95,000 |
* Mr Wright was appointed Chairman on 26 November 2021
** Mr Morris was appointed as non-executive Director of the Company and Chairman of the Audit Committee on 10 December 2021.
*** Mr Harris resigned as director on 26 November 2021.
The Company's benchmark is the MXGBIM. The graph below shows the Company's long-term total return performance (Share price return plus dividends paid) compared with the MXGBIM since the inception of MLCM (which is when the current Management team formed) being 22 September 2015.
Source: Bloomberg.

The table below shows the proportion of the Company's income spent on pay.
| 2024 £'000 |
2023 £'000 |
% Change |
|
|---|---|---|---|
| Dividends payable to Shareholders in respect of the financial year |
8,441 | 5,626 | 50.0 |
| Management fee | 1,458 | 532 | 174.1 |
| Total remuneration paid to Directors | 102 | 95 | 7.3 |
There is no requirement under the Company's Articles of Association for Directors to hold Shares in the Company.
The interests of the current Directors and their connected persons in the voting rights of the Company are set out below:
| As at 31 July 2024 No. of Shares |
As at 31 July 2023 No. of Shares |
|
|---|---|---|
| Daniel Wright** (Chairman) | 144,542** | 124,542** |
| Brett Miller | 1,734* | 1,734* |
| Daren Morris | 38,000 | 40,000 |
| Sir James Waterlow | 15,000 | 15,000 |
* This includes 734 Shares of which the beneficial interests are held by Mr Miller's family members.
** This includes 95,086 Shares (2023: 95,086 Shares) of which the beneficial interests are held by Mr Wright's family members.
Between 31 July 2024 and the date of this Report, Daniel Wright purchased a further 5,000 shares, taking his total beneficial interest to 149,542 shares.
The Directors' Remuneration Report for the year ended 31 July 2023 was approved at the Annual General Meeting held on 1 November 2023. The Directors' Remuneration Policy was last approved by Shareholders at the Annual General Meeting held on 1 November 2023. The votes cast on the Directors' Remuneration Report (including the Remuneration Policy) were as follows:
| Number of votes |
% of votes cast |
|
|---|---|---|
| For | 25,875,799 | 95.47 |
| Against | 1,227,943 | 4.53 |
| Total votes cast | 27,579,844 | 98.27 |
| Number of votes withheld | 476,102 | 1.73 |
The Directors' Remuneration Report was approved by the Board of Directors and signed on its behalf by:
Chairman
25 September 2024
This Remuneration Policy was approved by Shareholders at the Annual General Meeting on 1 November 2023. The policy provisions set out below will apply until they are next put to Shareholders for approval, which must be at intervals of at least once every three years, or the Remuneration Policy is varied, in which event, Shareholder approval for the new Remuneration Policy will be sought at the forthcoming Annual General Meeting. Notwithstanding this, the Board wishes to put the Remuneration Policy to Shareholders for approval annually.
The Board reviews and sets the level of remuneration payable to each Director annually.
The Company's Articles of Association limit the aggregate fees payable to the Directors to a total of £500,000 per annum. Subject to this overall limit, it is the Board's policy that the remuneration of Directors should be set at a level that is commensurate with the duties and responsibilities of the role. Remuneration levels elsewhere in the investment trust industry and all other relevant information are taken in account when considering Directors' fees. The Board considers that the current policy to remunerate the Directors by way of fixed fees is appropriate to the Company's present circumstances and there are no plans to introduce any alternative remuneration schemes.
Directors are not eligible for bonuses, pension benefits, Share options, long-term incentive schemes or other benefits. It is the Board's policy that Directors do not have service contracts but are provided with letters of appointment as a non-executive Director.
| Component | Director | Rate at 1 August 2024 |
Purpose of Remuneration |
|---|---|---|---|
| Annual fee | Chairman | £35,000 | Commitment as Chairman1 |
| Annual fee | Chairman of the Audit Committee |
£30,000 | Commitment as Audit Committee Chairman1 |
| Annual fee | Independent Director |
£27,000 | Commitment as an independent non-executive Director2 |
| Annual fee | Non-independent Director |
£25,000 | Commitment as a non-independent non-executive Director3 |
| Expenses | All Directors | N/A | Reimbursement of expenses incurred in the performance of duties as a Director |
1 The Company's policy is for the Chairman and the Audit Committee Chairman to be paid higher fees than the other Directors to reflect the more onerous roles.
2 The Company's Articles of Association limit the aggregate fees payable to the Board of Directors to a total of £500,000 per annum.
3 The Company's policy is to apply a discount to the fee paid to a non-independent Director.
Fees for any new Director appointed will be on the above basis. Fees payable in respect of subsequent periods will be determined by the Board following an annual review.
Any views expressed by Shareholders on the fees being paid to Directors would be taken into consideration by the Board. There are no performance conditions attaching to the remuneration of the Directors as the Board does not consider such arrangements or benefits necessary or appropriate for non‑executive Directors. Under the Directors' letters of appointment, there is a notice period of six months and no compensation is payable to a Director on loss of office.
The Directors are responsible for preparing the Company's Annual Report and Financial Statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare Financial Statements for each financial period. Under that law, they have elected to prepare the Financial Statements in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union. Under Company law, the Directors must not approve the Financial Statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.
In preparing the Financial Statements, the Directors are required to:
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy, at any time, the financial position of the Company and to enable them to ensure that the Financial Statements comply with the Companies Act 2006 and Article 4 of the IAS Regulation. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Under applicable law and regulations, the Directors are also responsible for preparing a Strategic Report, Directors' Report, Directors' Remuneration Report and Corporate Governance Statement that comply with that law and those regulations, and ensuring that the Annual Report includes information required by the Listing Rules and Disclosure Guidance and Transparency Rules of the FCA.
The Financial Statements are published on the Company's website, www.mlcapman.com/manchester-london-investment-trust-plc, which is maintained on behalf of the Company by the Manager. The Manager has agreed to maintain, host, manage and operate the Company's website and to ensure that it is accurate and up-to-date and operated in accordance with applicable law. The work carried out by the Auditor does not involve consideration of the maintenance and integrity of this website and accordingly, the Auditor accepts no responsibility for any changes that have occurred to the Financial Statements since they were initially presented on the website. Visitors to the website need to be aware that legislation in the United Kingdom covering the preparation and dissemination of the Financial Statements may differ from legislation in their jurisdiction.
We confirm that to the best of our knowledge:
The Directors consider that the Annual Report and Financial Statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for Shareholders to assess the Company's position and performance, business model and strategy.
On behalf of the Board
Chairman
25 September 2024

In our opinion the Financial Statements of Manchester and London Investment Trust plc (the 'Company'):
We have audited the Financial Statements which comprise:
The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom adopted international accounting standards and the Statement of Recommended Practice issued by the Association of Investment Companies ("SORP") in July 2022 "Financial Statements of Investment Trust Companies and Venture Capital Trusts".
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the Financial Statements section of our report.
We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the Financial Statements in the UK, including the Financial Reporting Council's (the 'FRC's') Ethical Standard as applied to listed public interest entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We confirm that we have not provided any non-audit services prohibited by the FRC's Ethical Standard to the Company.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
| The key audit matter that we identified in the current year was: | |
|---|---|
| • Valuation and existence of listed investments |
|
| Within this report, key audit matter is identified as follows: | |
| Key audit matters | Newly identified |
| Increased level of risk | |
| Similar level of risk | |
| Decreased level of risk | |
| Materiality | The materiality that we used in the current year was £3.34m which was determined on the basis of 1% of net assets. |
| Scoping | We performed our audit scoping based upon quantitative and qualitative risk assessment factors for each account balance recorded as at 31 July 2024. |
| Significant changes in our approach |
There have been no significant changes to our audit approach in the current year. |
In auditing the Financial Statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the Financial Statements is appropriate.
Our evaluation of the Directors' assessment of the Company's ability to continue to adopt the going concern basis of accounting included:
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the Financial Statements are authorised for issue.
In relation to the reporting on how the Company has applied the UK Corporate Governance Code, we have nothing material to add or draw attention to in relation to the Directors' statement in the Financial Statements about whether the Directors considered it appropriate to adopt the going concern basis of accounting.
Our responsibilities and the responsibilities of the Directors with respect to going concern are described in the relevant sections of this report.
Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the Financial Statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) that we identified. These matters included those which had the greatest effect on: the overall audit strategy; the allocation of resources in the audit; and directing the efforts of the engagement team.
These matters were addressed in the context of our audit of the Financial Statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
| 5.1. Valuation and existence of listed investments | |||||
|---|---|---|---|---|---|
| Key audit matter description |
The listed investments of the company of £309m (2023: £188.3m) make up 92.5% (2023: 85%) of total assets of the company at 31 July 2024. |
||||
| There is a risk that the listed investments may not be valued correctly or may not represent the assets of the company. Given the nature and size of the balance and its importance to the company, we have considered that there is a potential risk of fraud in this area. |
|||||
| See the accounting policy in note 1 of the Financial Statements and also note 9 of the Financial Statements. |
|||||
| How the scope of our audit responded to the key audit matter |
We performed the following procedures to address the key audit matter identified: |
||||
| • inspected the internal controls report over the administrator to obtain an understanding of relevant controls; |
|||||
| • tested the controls relating to valuation and existence of listed investments for the period of 7 months between the date of the internal controls report and the company's year end; |
|||||
| • agreed 100% of the company's listed investment portfolio at the year end to confirmations received directly from the depositary; and |
|||||
| • agreed 100% of the bid prices of listed investments on the investment ledger at year end to closing bid prices published by an independent pricing source. |
|||||
| Key observations | Based on the work performed, we concluded that the valuation and existence of listed investments are appropriate. |
We define materiality as the magnitude of misstatement in the Financial Statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be changed or influenced. We use materiality both in planning the scope of our audit work and in evaluating the results of our work.
Based on our professional judgement, we determined materiality for the Financial Statements as a whole as follows:
| Materiality | £3.34m (2023: £2.2m) |
|---|---|
| Basis for determining materiality |
1% of net assets (2023: 1% of net assets) |
| Rationale for the benchmark applied |
We have used net assets as our materiality benchmark as we consider it to be the most relevant indicator of the Company's performance for the users of the Financial Statements, as well as being a key driver of shareholder value. |

We set performance materiality at a level lower than materiality to reduce the probability that, in aggregate, uncorrected and undetected misstatements exceed the materiality for the Financial Statements as a whole. Performance materiality was set at 70% of materiality for the 2024 audit (2023: 70%). In determining performance materiality, we considered the following factors:
We agreed with the Audit Committee that we would report to the Committee all audit differences in excess of £0.17m (2023: £0.11m), as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds. We also report to the Audit Committee on disclosure matters that we identified when assessing the overall presentation of the Financial Statements.
Our audit scope was determined by obtaining an understanding of the Company and its environment, including internal controls, and assessing the risks of material misstatement. Audit work to respond to the risks of material misstatement was performed directly by the audit engagement team.
In assessing the company's control environment, we considered controls in place at the company's service organisation which acts as administrator. As part of this, we reviewed the System and Organisation Controls (SOC 1) Report of the service organisation and have taken a controls reliance approach in respect of the controls relating to valuation and existence of listed investments. For the period of 7 months between the date of the SOC1 report and the company's year end, we tested the controls relating to valuation and existence of listed investments. We also reviewed the controls report of the service organisation in respect of general IT controls. Further, we obtained an understanding of relevant business processes and controls that address the risk of material misstatement in financial reporting.
In planning our audit, we have considered the potential impact of climate change on the business and its Financial Statements. The company continues to develop its model for assessing and assigning an ESG score on existing and potential investments based on assessment of the potential impacts of environmental, social and governance ("ESG") related risks, including climate change, as outlined on pages 42 and 43. As a part of our audit, we process of identifying climate-related risks and the impact on the company's Financial Statements. We have read the climate related disclosures in the annual report to consider whether they are materially consistent with the Financial Statements and our knowledge obtained in the audit.
The other information comprises the information included in the annual report, other than the Financial Statements and our auditor's report thereon. The Directors are responsible for the other information contained within the annual report.
Our opinion on the Financial Statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the Financial Statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated.
If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the Financial Statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
As explained more fully in the Directors' responsibilities statement, the Directors are responsible for the preparation of the Financial Statements and for being satisfied that they give a true and fair view, and for such internal control as the Directors determine is necessary to enable the preparation of Financial Statements that are free from material misstatement, whether due to fraud or error.
In preparing the Financial Statements, the Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.
Our objectives are to obtain reasonable assurance about whether the Financial Statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Financial Statements.
A further description of our responsibilities for the audit of the Financial Statements is located on the FRC's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:
As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following area: valuation and existence of listed investments. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override.
We also obtained an understanding of the legal and regulatory framework that the Company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the Financial Statements. The key laws and regulations we considered in this context included the UK Companies Act, Listing Rules, and Investment Trust Tax Legislations.
In addition, we considered provisions of other laws and regulations that do not have a direct effect on the Financial Statements but compliance with which may be fundamental to the Company's ability to operate or to avoid a material penalty.
As a result of performing the above, we identified the valuation and existence of listed investments as a key audit matter related to the potential risk of fraud. The key audit matters section of our report explains the matter in more detail and also describes the specific procedures we performed in response to that key audit matter.
In addition to the above, our procedures to respond to risks identified included the following:
We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, including internal specialists, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
In our opinion the part of the Directors' remuneration report to be audited has been properly prepared in accordance with the Companies Act 2006.
In our opinion, based on the work undertaken in the course of the audit:
In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified any material misstatements in the strategic report or the Directors' report.
The Listing Rules require us to review the Directors' statement in relation to going concern, longer-term viability and that part of the Corporate Governance Statement relating to the Company's compliance with the provisions of the UK Corporate Governance Code specified for our review.
Based on the work undertaken as part of our audit, we have concluded that each of the following elements of the Corporate Governance Statement is materially consistent with the Financial Statements and our knowledge obtained during the audit:
14.1.Adequacy of explanations received and accounting records
Under the Companies Act 2006 we are required to report to you if, in our opinion:
We have nothing to report in respect of these matters.
Under the Companies Act 2006 we are also required to report if in our opinion certain disclosures of Directors' remuneration have not been made or the part of the Directors' remuneration report to be audited is not in agreement with the accounting records and returns.
We have nothing to report in respect of these matters.
Following the recommendation of the Audit Committee, we were appointed by the Board of Directors on 28 November 2016 to audit the Financial Statements for the year ending 31 July 2017 and subsequent financial periods. The period of total uninterrupted engagement including previous renewals and reappointments of the firm is 8 years, covering the years ending 31 July 2017 to 31 July 2024.
Our audit opinion is consistent with the additional report to the Audit Committee we are required to provide in accordance with ISAs (UK).
This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Michael Caullay (Senior statutory auditor) For and on behalf of Deloitte LLP Statutory Auditor Glasgow, United Kingdom
25 September 2024
66 Manchester and London Investment Trust plc NOTES FORMING PART OF THE FINANCIAL STATEMENTS continued For the year ended 31 July 2024 Annual Report & Financial Statements 2024

For the year ended 31 July 2024
| 2024 | 2023 | ||||||
|---|---|---|---|---|---|---|---|
| Notes | Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
|
| Gains | |||||||
| Gains on investments at fair value through profit or loss |
9 | 357 | 123,556 | 123,913 | 296 | 29,284 | 29,580 |
| Investment income | 2 | 1,092 | – | 1,092 | 575 | – | 575 |
| Bank interest | 2 | 1,354 | – | 1,354 | 1,754 | – | 1,754 |
| Gross return | 2,803 | 123,556 | 126,359 | 2,625 | 29,284 | 31,909 | |
| Expenses | |||||||
| Management fee | 3 | (1,458) | – | (1,458) | (532) | – | (532) |
| Other operating expenses | 4 | (563) | – | (563) | (499) | – | (499) |
| Total expenses | (2,021) | – | (2,021) | (1,031) | – | (1,031) | |
| Return before finance costs and tax |
782 | 123,556 | 124,338 | 1,594 | 29,284 | 30,878 | |
| Finance costs | 5 | (68) | (2,966) | (3,034) | (38) | (2,009) | (2,047) |
| Return on ordinary activities before tax |
714 | 120,590 | 121,304 | 1,556 | 27,275 | 28,831 | |
| Taxation | 6 | (144) | – | (144) | (77) | – | (77) |
| Return on ordinary activities after tax |
570 | 120,590 | 121,160 | 1,479 | 27,275 | 28,754 | |
| Return per Share | pence | pence | pence | pence | pence | pence | |
| Basic and fully diluted | 8 | 1.42 | 300.03 | 301.45 | 3.67 | 67.78 | 71.45 |
The total column of this statement is the Income Statement of the Company prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006. The supplementary revenue return and capital return columns are presented in accordance with the Statement of Recommended Practice issued by the Association of Investment Companies ("AIC SORP").
All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued during the year.
There is no other comprehensive income, and therefore the return for the year after tax is also the total comprehensive income.
The notes on pages 72 to 89 form part of these Financial Statements.
For the year ended 31 July 2024
| Notes | Share capital £'000 |
Share premium £'000 |
Special reserve** £'000 |
Capital reserve* £'000 |
Retained earnings** £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|
| Balance at 1 August 2023 | 10,132 | 25,888 | 94,338 | 91,021 | – | 221,379 | |
| Changes in equity for 2024 | |||||||
| Ordinary shares bought back and held in treasury |
14 | – | – | – | – | – | – |
| Total comprehensive income | – | – | – | 120,590 | 570 | 121,160 | |
| Dividends paid | 7 | – | – | (7,870) | – | (570) | (8,440) |
| Balance at 31 July 2024 | 10,132 | 25,888 | 86,468 | 211,611 | – | 334,099 | |
| Balance at 1 August 2022 | 10,132 | 25,888 | 98,780 | 63,746 | – | 198,546 | |
| Changes in equity for 2023 | |||||||
| Ordinary shares bought back and held in treasury |
14 | – | – | (289) | – | – | (289) |
| Total comprehensive income | – | – | – | 27,275 | 1,479 | 28,754 | |
| Dividends paid | 7 | – | – | (4,153) | – | (1,479) | (5,632) |
| Balance at 31 July 2023 | 10,132 | 25,888 | 94,338 | 91,021 | – | 221,379 |
* Within the balance of the capital reserve, £50,175,000 relates to realised gains (2023: £33,340,000). Realised gains are distributable by way of a dividend. The remaining £161,436,000 relates to unrealised gains on financial instruments (2023: £57,681,000) and is non-distributable.
** Fully distributable.
The notes on pages 72 to 89 form part of these Financial Statements.
As at 31 July 2024
| Notes | 2024 £'000 |
2023 £'000 |
|
|---|---|---|---|
| Non-current assets | |||
| Investments at fair value through profit or loss | 9 | 309,002 | 188,264 |
| Current assets | |||
| Unrealised derivative assets | 13 | 4,866 | 5,680 |
| Trade and other receivables | 10 | 419 | 147 |
| Cash and cash equivalents | 11 | 7,187 | 17,049 |
| Cash collateral receivable from brokers | 13 | 16,371 | 12,186 |
| 28,843 | 35,062 | ||
| Creditors – amounts falling due within one year | |||
| Unrealised derivative liabilities | 13 | (3,248) | (1,411) |
| Trade and other payables | 12 | (498) | (277) |
| Cash collateral payable to brokers | 13 | – | (259) |
| (3,746) | (1,947) | ||
| Net current assets | 25,097 | 33,115 | |
| Net assets | 334,099 | 221,379 | |
| Capital and reserves | |||
| Ordinary Share Capital | 14 | 10,132 | 10,132 |
| Share premium | 25,888 | 25,888 | |
| Special Reserves | 86,468 | 94,338 | |
| Capital reserve | 211,611 | 91,021 | |
| Retained earnings | – | – | |
| Total equity | 334,099 | 221,379 | |
| Basic and fully diluted NAV per Share | 15 | 831.24p | 550.79p |
| Number of Shares in issue excluding treasury | 14 | 40,193,018 | 40,193,018 |
The Financial Statements on pages 68 to 89 were approved by the Board of Directors and authorised for issue on 25 September 2024 and are signed on its behalf by:
Chairman
Manchester and London Investment Trust Public Limited Company Company Number: 01009550
For the year ended 31 July 2024
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Cash flow from operating activities | ||
| Return on operating activities before tax | 121,304 | 28,831 |
| Interest expense | 3,034 | 2,047 |
| Gains on investments held at fair value through profit or loss | (123,533) | (27,810) |
| Increase in receivables | (34) | (116) |
| Increase in payables | 163 | 26 |
| Exchange gains on Currency Balances | (23) | (1,473) |
| Tax | (144) | (77) |
| Net cash generated from operating activities | 767 | 1,428 |
| Cash flow from investing activities | ||
| Purchases of investments | (79,749) | (116,934) |
| Sales proceeds | 65,875 | 73,120 |
| Derivative instrument cashflows | 14,638 | 17,023 |
| Net cash inflow/(outflow) from investing activities | 764 | (26,791) |
| Cash flow from financing activities | ||
| Ordinary shares bought back and held in treasury | – | (289) |
| Equity dividends paid | (8,440) | (5,632) |
| Interest paid | (2,976) | (1,980) |
| Net cash used in financing activities | (11,416) | (7,901) |
| Net decrease in cash and cash equivalents | (9,885) | (33,264) |
| Exchange gains on Currency Balances | 23 | 1,473 |
| Cash and cash equivalents at beginning of year | 17,049 | 48,840 |
| Cash and cash equivalents at end of year | 7,187 | 17,049 |
For the year ended 31 July 2024
Manchester and London Investment Trust plc is a public limited company incorporated in the UK and registered in England and Wales. The principal activity of the Company is that of an investment trust company within the meaning of Sections 1158/1159 of the Corporation Tax Act 2010 and its investment approach is detailed in the Strategic Report.
The Company's Financial Statements have been prepared in accordance with United Kingdom adopted international accounting standards in conformity with the requirements of the Companies Act 2006. The Financial Statements have also been prepared in accordance with the AIC SORP for the financial statements of investment trust companies and venture capital trusts.
In order to better reflect the activities of an investment trust company and in accordance with the AIC SORP, supplementary information which analyses the Statement of Comprehensive Income between items of revenue and capital nature has been prepared alongside the Statement of Comprehensive Income.
The Financial Statements are presented in Sterling, which is the Company's functional currency as the UK is the primary environment in which it operates, rounded to the nearest £'000, except where otherwise indicated.
The financial statements have been prepared on a going concern basis and on the basis that approval as an investment trust company will continue to be met.
The Directors have made an assessment of the Company's ability to continue as a going concern and are satisfied that the Company has adequate resources to continue in operational existence for a period of at least 12 months from the date when these financial statements were approved.
In making the assessment, the Directors of the Company have considered the likely impacts of international and economic uncertainties on the Company, operations and the investment portfolio. These include, but are not limited to, the impact of another pandemic, the war in Ukraine, political instability across Europe, supply shortages and inflationary pressures.
The Directors noted that the Company, with the current cash balance and holding a portfolio of listed investments, is able to meet the obligations of the Company as they fall due. The current cash balance, enables the Company to meet any funding requirements and finance future additional investments. The Company is a closed-end fund, where assets are not required to be liquidated to meet day to day redemptions.
The Directors have completed stress tests assessing the impact of changes in market value and income with associated cash flows. In making this assessment, they have considered plausible downside scenarios. These tests were driven by the possible effects of continuation of the COVID-19 pandemic but, as an arithmetic exercise, apply equally to any other set of circumstances in which asset value and income are significantly impaired. The conclusion was that in a plausible downside scenario the Company could continue to meet its liabilities. Whilst the economic future is uncertain, and the Directors believe that it is possible the Company could experience further reductions in income and/or market value, the opinion of the Directors is that this should not be to a level which would threaten the Company's ability to continue as a going concern.
The Directors, the Manager and other service providers have put in place contingency plans to minimise disruption. Furthermore, the Directors are not aware of any material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern, having taken into account the liquidity of the Company's investment portfolio and the Company's financial position in respect of its cash flows, borrowing facilities and investment commitments (of which there are none of significance). Therefore, the financial statements have been prepared on the going concern basis.
The Directors are of the opinion that the Company is engaged in a single segment of business, being investment business. The Company primarily invests in companies listed on recognised international exchanges.
In the year under review, the Company has applied amendments to IFRS issued by the IASB adopted in conformity with UK adopted international accounting standards. These include annual improvements to IFRS, changes in standards, legislative and regulatory amendments, changes in disclosure and presentation requirements. This incorporated:
The adoption of the changes to accounting standards has had no material impact on these or prior years' financial statements. There are amendments to IAS/IFRS that will apply from 1 August 2024 as follows:
The Directors do not anticipate the adoption of these will have a material impact on the financial statements.
The preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of policies and the reported amounts in the financial statements. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.
There were no significant accounting estimates or critical accounting judgements in the year.
For the year ended 31 July 2024
Investments are measured initially, and at subsequent reporting dates, at fair value through profit and loss, and derecognised at trade date where a purchase or sale is under a contract whose terms require delivery within the timeframe of the relevant market. For listed equity investments, this is deemed to be closing prices.
Changes in fair value of investments are recognised in the Statement of Comprehensive Income as a capital item. On disposal, realised gains and losses are also recognised in the Statement of Comprehensive Income as capital items.
All investments for which fair value is measured or disclosed in the Financial Statements are categorised within the fair value hierarchy in note 9.
The Company may use a variety of derivative instruments, including equity swaps (also referred to as contracts for differences), futures, forwards and options under master agreements with the Company's derivative counterparties to enable the Company to gain long and short exposure on individual securities.
The Company recognises financial assets and financial liabilities when it becomes a party to the contractual provisions of the instrument. Listed options and futures contracts are recognised at fair value through profit or loss valued by reference to the underlying market value of the corresponding security, traded prices and/or third party information.
Notional dividend income arising on long positions is recognised in the Statement of Comprehensive Income as revenue. Interest expenses on open long positions are allocated to capital. All remaining interest or financing charges on derivative contracts are allocated to the revenue account.
Unrealised changes to the value of securities in relation to derivatives are recognised in the Statement of Comprehensive Income as capital items.
Transactions denominated in foreign currencies are converted to Sterling at the actual exchange rate as at the date of the transaction. Monetary assets and liabilities and non-monetary assets held at fair value denominated in foreign currencies at the year end are translated at the Statement of Financial Position date. Any gain or loss arising from a change in exchange rate subsequent to the date of the transaction is included as an exchange gain or loss in the capital reserve or the revenue account depending on whether the gain or loss is capital or revenue in nature.
Cash comprises cash in hand and overdrafts. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to insignificant risk of changes in value.
For the purposes of the Statement of Financial Position and the Statement of Cash Flows, cash and cash equivalents consist of cash and cash equivalents as defined above, net of outstanding bank overdrafts when applicable.
Cash held in margin/collateral accounts at the Company's brokers is presented as Cash collateral receivable from brokers in the financial statements. Any cash collateral owed back to the brokers on marked to market gains of Equity Swaps is shown in the financial statements as Cash collateral payable to brokers.
Trade receivables, trade payables and short-term borrowings are measured at amortised cost.
Revenue is recognised when it is probable that economic benefits associated with a transaction will flow to the Company and the revenue can be reliably measured.
Dividends from overseas companies are shown gross of any non-recoverable withholding taxes which are disclosed separately in the Statement of Comprehensive Income.
Dividends receivable on quoted equity shares are taken to revenue on an ex-dividend basis. Dividends receivable on equity shares where no ex-dividend date is quoted are brought into account when the Company's right to receive payment is established.
All other income is accounted for on a time-apportioned basis and recognised in the Statement of Comprehensive Income.
All expenses are accounted for on an accruals basis and are charged to revenue. All other administrative expenses are charged through the revenue column in the Statement of Comprehensive Income.
Finance costs are accounted for on an accruals basis.
Financing charged by the Prime Brokers on open long positions are allocated to capital, with other finance costs being allocated to revenue.
The charge for taxation is based on the net revenue for the year and any deferred tax.
Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amount for financial reporting purposes at the reporting date. Deferred tax assets are only recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of timing differences can be deducted. In line with recommendations of the AIC SORP, the allocation method used to calculate the tax relief on expenses charged to capital is the "marginal" basis. Under this basis, if taxable income is capable of being offset entirely by expenses charged through the revenue account, then no tax relief is transferred to the capital account.
No taxation liability arises on gains from sales of investments by the Company by virtue of its investment trust status. However, the net revenue (excluding investment income) accruing to the Company is liable to corporation tax at prevailing rates.
Dividends to Shareholders are recognised as a liability in the period in which they are approved and are taken to the Statement of Changes in Equity. Dividends declared and approved by the Company after the Statement of Financial Position date have not been recognised as a liability of the Company at the Statement of Financial Position date.
The share capital is the nominal value of issued ordinary shares and is not distributable.
For the year ended 31 July 2024
The Share premium account represents the accumulated premium paid for Shares issued in previous periods above their nominal value less issue expenses. This is a reserve forming part of the non-distributable reserves. The following items are taken to this reserve:
The special reserve was created by a cancellation of the share premium account increasing the distributable reserves of the Company. The special reserve is distributable, and the following items are taken to this reserve:
The following are taken to capital reserve:
The revenue reserve represents accumulated revenue account profits and losses. The surplus accumulated profits are distributable by way of dividends.
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Dividends from listed investments | 1,092 | 575 |
| Bank interest | 1,354 | 1,754 |
| 2,446 | 2,329 | |
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Base fee | 1,399 | 473 |
| Risk management and valuation fee | 59 | 59 |
| 1,458 | 532 |
The Management Fee payable to the Manager is equal to 0.5% per annum of the Company's NAV (the "Base Fee"), calculated as at the last business day of each calendar month (the "Calculation Date"), and is paid monthly arrears. An uplift of 0.25% of the NAV will be applied to the fee, should the performance of the Company over the 36-month period to the Calculation Date be above that of the Company's benchmark. Should the performance of the Company over the 36-month period to the Calculation Date be below that of the Company's benchmark, a downward adjustment of 0.25% of the NAV will be applied to the fee.
It was announced on 2 September 2024, that with effect 1 September 2024, the Board agreed with the Manager a new tiered management fee replacing the current fee arrangements.
There will be no performance fee payable to the Manager.
There will be no change to the Risk Management and Valuation fee, however, the fee will be adjusted annually in January by the UK Consumer Prices Index ("CPI") with the first increase being in January 2026 on the basis of the January 2026 CPI (percentage change over 12 months) figure.
The Board believes that the new fee structure offers a simpler and more predictable arrangement, removes the unnecessary volatility in ongoing charges for shareholders and allows the Manager to better plan for the future and broaden the expertise of the management team supporting the Company. It also addresses concerns raised by proxy advisors and compliance departments over the variability of the fee arrangements.
Also, the Board believes that the changes have the potential to generate cost savings for shareholders in both the short and long-term, in particular, if the Company were to see a material increase in NAV.
In addition, a Risk Management and Valuation fee equating to £59,000 on an annualised basis is charged by the AIFM. The Manager is also reimbursed any expenses incurred by it on behalf of the Company.
For the year ended 31 July 2024
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Directors' fees | 102 | 95 |
| Auditors' remuneration | 37 | 35 |
| Registrar fees | 32 | 27 |
| Depositary fees | 101 | 69 |
| Other expenses | 291 | 273 |
| 563 | 499 |
Other operating expenses include irrecoverable VAT where appropriate, excluding the Auditors' and Directors' remuneration which have been shown net of VAT.
No non-audit services were provided by Deloitte LLP in the year to 31 July 2024.
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Charged to revenue | 68 | 38 |
| Charged to capital* | 2,966 | 2,009 |
| 3,034 | 2,047 |
* Finance costs charged to capital relate to interest on equity swaps.
a) Analysis of charge in year.
| Year to 31 July 2024 |
Year to 31 July 2023 |
|||||
|---|---|---|---|---|---|---|
| Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
|
| Current tax: | ||||||
| Overseas tax not recoverable | 144 | – | 144 | 77 | – | 77 |
| 144 | – | 144 | 77 | – | 77 |
b) The current taxation charge for the year is lower than the standard rate of Corporation Tax in the UK of 25% (2023: 25%).
The differences are explained below:
| Net return before taxation | 714 | 120,590 | 121,304 | 1,556 | 27,275 | 28,831 |
|---|---|---|---|---|---|---|
| Theoretical tax at UK corporation tax rate of 25% (2023: 21%)* |
178 | 30,147 | 30,325 | 327 | 5,728 | 6,055 |
| Effects of: | ||||||
| UK dividends that are not taxable | – | – | – | (6) | – | (6) |
| Foreign dividends that are not taxable | (208) | – | (208) | (115) | – | (115) |
| Non-taxable investment gains | – | (30,889) | (30,889) | – | (6,150) | (6,150) |
| Offshore income gains | 63 | – | 63 | – | – | – |
| Irrecoverable overseas tax | 144 | – | 144 | 77 | – | 77 |
| Unrelieved excess expenses | (33) | 742 | 709 | (206) | 422 | (216) |
| Total tax charge | 144 | – | 144 | 77 | – | 77 |
* The theoretical tax rate is calculated using a blended tax rate over the year.
c) Factors that may affect future tax charges.
At 31 July 2024, there is an unrecognised deferred tax asset, measured at the latest enacted tax rate of 25%, of £4,775,000 (2023: £4,070,000). This deferred tax asset relates to surplus management expenses and non trade loan relationship debits. It is unlikely that the company will generate sufficient taxable profits in the foreseeable future to recover these amounts and therefore the asset has not been recognised in the year, or in prior years.
As at 31 July 2024, the company has unrelieved capital losses of £9,329,000 (2023: £9,329,000). There is therefore, a related unrecognised deferred tax asset, measured at the latest enacted rate of 25%, of £2,332,000 (2023: £2,332,000). These capital losses can only be utilised to the extent that the company does not qualify as an investment trust in the future and, as such, the asset has not been recognised.
For the year ended 31 July 2024
| Amounts recognised as distributions to equity holders in the year: | 2024 £'000 |
2023 £'000 |
|---|---|---|
| Final ordinary dividend for the year ended 31 July 2023 of 7.0p (2022: 7.0p) per share |
2,813 | 2,819 |
| Interim ordinary dividend for the year ended 31 July 2024 of 7.0p (2023: 7.0p) per share |
2,813 | 2,813 |
| Special dividend for the year ended 31 July 2024 of 7.0p (2023: Nil) per share |
2,814 | – |
| 8,440 | 5,632 | |
The Directors are proposing a final dividend of 7.0p for the financial year 2024.
These proposed dividends have been excluded as a liability in these Financial Statements in accordance with IFRS.
We also set out below the total dividend payable in respect of the financial year, which is the basis on which the requirements of Section 1158 of the Corporation Tax Act 2010 are considered.
Included in the dividend distributions to equity holders in the year is £7,870,000 (2023: £4,153,000) paid from special reserve.
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Interim ordinary dividend for the year ended 31 July 2024 of 7.0p (2023: 7.0p) per Share |
2,813 | 2,813 |
| Special dividend for the year ended 31 July 2024 of 7.0p (2023: Nil) per share |
2,814 | – |
| Proposed final ordinary dividend* for the year ended 31 July 2024 of 7.0p (2023: 7.0p) per Share |
2,814* | 2,813 |
| 8,441 | 5,626 |
* Based on Shares in circulation on 31 July 2024 (excluding Shares held in treasury).
| Net Return £'000 |
2024 Weighted Average Shares |
Total (p) |
Net Return £'000 |
2023 Weighted Average Shares |
Total (p) |
|
|---|---|---|---|---|---|---|
| Basic and fully diluted return: | ||||||
| Net revenue return after taxation | 570 | 40,193,018 | 1.42 | 1,479 | 40,242,768 | 3.67 |
| Net capital return after taxation | 120,590 | 40,193,018 | 300.03 | 27,275 | 40,242,768 | 67.78 |
| Total | 121,160 | 40,193,018 | 301.45 | 28,754 | 40,242,768 | 71.45 |
Basic revenue, capital and total return per Share is based on the net revenue, capital and total return for the period and on the weighted average number of Shares in issue of 40,193,018 (2023: 40,242,768).
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Analysis of investment portfolio movements | ||
| Opening cost at 1 August | 136,155 | 82,500 |
| Opening unrealised appreciation at 1 August | 52,109 | 45,611 |
| Opening fair value at 1 August | 188,264 | 128,111 |
| Movements in the year | ||
| Purchases at cost | 79,749 | 116,009 |
| Sales of investments | (66,024) | (73,432) |
| Realised profit on sales | 2,006 | 11,078 |
| Increase in unrealised appreciation | 105,007 | 6,498 |
| Closing fair value at 31 July | 309,002 | 188,264 |
| Closing cost at 31 July | 151,886 | 136,155 |
| Closing unrealised appreciation at 31 July Closing fair value at 31 July |
157,116 309,002 |
52,109 188,264 |
Financial assets of the Company are carried in the Statement of Financial Position at fair value. The fair value is the amount at which the asset could be sold or the liability transferred in an orderly transaction between market participants, at the measurement date, other than a forced or liquidation sale. The Company measures fair values using the following hierarchy that reflects the significance of the inputs used in making the measurements.
Categorisation within the hierarchy has been determined on the basis of the lowest level input that is significant to the fair value measurement of the relevant assets as follows:
For the year ended 31 July 2024
The tables below set out fair value measurements of financial instruments as at the year end, by their category in the fair value hierarchy into which the fair value measurement is categorised.
Financial assets/liabilities at fair value through profit or loss at 31 July 2024
| Level 1 £'000 |
Level 2 £'000 |
Total £'000 |
|
|---|---|---|---|
| Investments | 309,002 | – | 309,002 |
| Unrealised Derivative Assets | – | 4,866 | 4,866 |
| Unrealised Derivative Liability | – | (3,248) | (3,248) |
| Total | 309,002 | 1,618 | 310,620 |
| Level 1 £'000 |
Level 2 £'000 |
Total £'000 |
|
|---|---|---|---|
| Investments | 188,264 | – | 188,264 |
| Unrealised Derivative Assets | – | 5,680 | 5,680 |
| Unrealised Derivative Liability | – | (1,411) | (1,411) |
| Total | 188,264 | 4,269 | 192,533 |
There have been no transfers during the year between Level 1 and 2 fair value measurements.
During the year, the Company incurred transaction costs of £154,000 (2023: £176,000) on the purchase and disposal of investments.
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Gains on sales of investments | 2,006 | 11,078 |
| Investment holding gains | 105,007 | 6,498 |
| Realised gains on derivatives | 17,684 | 7,238 |
| Unrealised (losses)/gains on derivatives | (1,252) | 3,309 |
| 123,445 | 28,123 | |
| Realised gains on currency balances and trade settlements | 111 | 1,161 |
| Dividend income in respect of equity swaps | 357 | 296 |
| 123,913 | 29,580 |
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Dividends receivable | 52 | 6 |
| Due from brokers | 237 | – |
| Interest receivable | 95 | 105 |
| Prepayments | 35 | 36 |
| 419 | 147 | |
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Cash and cash equivalents | 7,187 | 17,049 |
| 7,187 | 17,049 | |
As at the balance sheet date, the Company held shares valued at £11,000 (2023: £3,852,000) in the Morgan Stanley Sterling Liquidity fund, which has been classified as a Cash equivalent (see Note 1).
| 2024 £'000 |
2023 £'000 |
|
|---|---|---|
| Due to Brokers | 6 | – |
| Accruals | 492 | 277 |
| 498 | 277 | |
The Company may use a variety of derivative contracts under master agreements with the Company's derivative counterparties to enable it to gain long and short exposure, including Options and Equity Swaps (which are synthetic equities), and are valued by reference to the market values of the investments' underlying securities.
The sources of the return under the Equity Swap contracts (e.g. notional dividends, financing costs, interest returns and realised and unrealised gains and losses) are allocated to the revenue and capital accounts in alignment with the nature of the underlying source of income.
For the year ended 31 July 2024
The fair values of derivative financial assets are set out in the table below:
| 2024 Original £'000 |
2023 £'000 |
|
|---|---|---|
| Unrealised derivative assets | 4,866 | 5,680 |
| Cash collateral receivable from brokers | 16,371 | 12,186 |
| Unrealised derivative liabilities | (3,248) | (1,411) |
| Cash collateral payable to brokers | – | (259) |
The corresponding gross exposure on long equity swaps as at 31 July 2024 was £65,982,000 (2023: £60,756,000) and the total gross exposure of short equity swaps was £5,272,000 (2023: £5,203,000). The net marked to market futures and options total value as at 31 July 2024 was negative £1,697,000 (2023: negative £1,064,000).
As at 31 July 2024, the Company held cash and cash equivalent balances of £7,187,000 (2023: £17,049,000). The Company also pledged cash of £16,371,000 (2023: £12,186,000) on collateral accounts with counterparty brokers specifically for derivatives (including exchange traded derivatives positions and non-exchange traded swap positions). This cash represents collateral posted to broker deposit accounts in relation to amounts due to brokers in order to maintain open positions and constitute a number of types of margin required (such as initial, marked to market variation etc).
The nature of the Company's portfolio means that the Company gains significant exposure to a number of markets through Equity Swaps. The Company may use Equity Swaps to manage gearing. However, to the extent the Manager has elected not to be geared, the Company will generally hold a level of cash (or equivalent holding in the Cash Fund) on its balance sheet representative of the difference between the cost of purchasing investments directly and the lower initial cost of making a margin payment on an Equity Swap contract.
As at 31 July 2024, the Company also owed £nil (2023: £259,000) to brokers in respect of cash collateral received relating to amounts owed by these brokers to cover unrealised gains on open Equity Swaps on the Statement of Financial Position. To the extent there are unrealised losses on Equity Swap contracts uncovered by balances held at the broker, the Company will transfer deposit monies across to these broker margin deposit accounts. The Manager monitors margin positions on a daily basis to ensure any margin deposit balances are as expected and any amounts owed to the Company are transferred on a timely basis. In the event of default, a proportion of the monies held in the collateral accounts resides with the counterparty broker.
| 2024 | 2023 | |||
|---|---|---|---|---|
| Share capital | Number of Shares |
Nominal value £'000 |
Number of Shares |
Nominal value £'000 |
| Shares of 25p each issued and fully paid |
||||
| Balance as at 1 August | 40,528,238 | 10,132 | 40,528,238 | 10,132 |
| Shares issued | – | – | – | – |
| Balance as at 31 July | 40,528,238 | 10,132 | 40,528,238 | 10,132 |
| Treasury shares | ||||
| Balance as at 1 August | 335,220 | 258,183 | ||
| Buyback of Ordinary Shares into Treasury | – | 77,037 | ||
| Balance at end of year | 335,220 | 335,220 | ||
| Total Ordinary Share capital excluding Treasury shares |
40,193,018 | 40,193,018 |
No shares were issued during the year (2023: nil).
During the year, nil Ordinary Shares (2023: 77,037) were bought back and held in treasury for total cost of £nil.
| NAV per Share | Net assets attributable | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (p) | (p) | £'000 | £'000 | |
| Shares: basic and fully diluted | 831.24 | 550.79 | 334,099 | 221,379 |
The basic NAV per Share is based on net assets at the year end and 40,193,018 (2023: 40,193,018) Shares in issue, adjusted for any Shares held in Treasury.
The Company's investment objective and policy are detailed on pages 17 and 18.
The investing activities in pursuit of its investment objective involve certain inherent risks.
The Company's financial instruments can comprise:
The risks identified arising from the Company's financial instruments are market risk (which comprises market price risk and interest rate risk), liquidity risk and credit and counterparty risk. The Company may enter into derivative contracts to manage risk. The Board reviews and agrees policies for managing each of these risks, which are summarised below.
These policies remained unchanged since the beginning of the accounting period.
For the year ended 31 July 2024
Market risk arises mainly from uncertainty about future prices of financial instruments used in the Company's business. It represents the potential loss the Company might suffer through holding market positions by way of price movements, interest rate movements and exchange rate movements. The Company assesses the exposure to market risk when making each investment decision and these risks are monitored by the Manager on a regular basis and the Board at quarterly meetings with the Manager.
Details of the long equity exposures held at 31 July 2024 are shown on page 11.
If the price of these investments and equity swaps had increased by 5% at the reporting date with all other variables remaining constant, the capital return in the Statement of Comprehensive Income and the net assets attributable to equity holders of the Company would increase by £18,486,000 (2023: £12,191,000).
A 5% decrease in share prices would have resulted in an equal and opposite effect of £18,486,000 (2023: £12,191,000), on the basis that all other variables remain constant. This level of change is considered to be reasonable based on observation of current market conditions.
At the year end, the Company's direct equity exposure to market risk was as follows:
| Company | ||
|---|---|---|
| 2024 £'000 |
2023 £'000 |
|
| Equity long exposures | ||
| Investments held in equity form | 309,002 | 188,264 |
| Long exposure held in equity swap hedges | 65,982 | 60,756 |
| 374,984 | 249,020 | |
| Short exposure held in equity swap hedges | (5,272) | (5,203) |
| 369,712 | 243,817 | |
Interest rate risk arises from uncertainty over the interest rates charged by financial institutions. It represents the potential increased costs of financing for the Company. The Manager actively monitors interest rates and the Company's ability to meet its financing requirements throughout the year and reports to the Board. No sensitivity analysis is presented because, as at the financial year end, the Company held zero balances invested in bonds or fixed interest securities. The Company is charged interest on its Equity Swap positions but these may be partially offset with interest received on cash, collateral and cash equivalent balances.
Liquidity risk reflects the risk that the Company will have insufficient funds to meet its financial obligations as they fall due. The Directors have minimised liquidity risk by investing in a portfolio of quoted companies that are readily realisable.
The Company's uninvested funds are held almost entirely with the Prime Brokers or on deposits with UK banking institutions.
As at 31 July 2024, the financial liabilities comprised:
| Company | ||
|---|---|---|
| 2024 £'000 |
2023 £'000 |
|
| Unrealised derivative liabilities | 2,959 | 1,411 |
| Trade payables and accruals | 498 | 277 |
| Cash collateral payable to brokers | – | 259 |
| 3,457 | 1,947 |
The above liabilities are stated at amortised cost or fair value.
The Company manages liquidity risk through constant monitoring of the Company's gearing position to ensure the Company is able to satisfy any and all debts within the agreed credit terms.
Currency risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If Sterling had strengthened by 5% against all other currencies at the reporting date, with all other variables remaining constant, the total return in the Statement of Comprehensive Income and the net assets attributable to equity holders of the Company, assuming the Company held no balances in Sterling, would have decreased by £16,704,000 (2023: £11,069,000). If Sterling had weakened by 5% against all currencies, there would have been an equal and opposite effect. This level of change is considered to be reasonable based on observation of current market conditions.
The Company's material foreign currency exposures are laid out below.
| As at 31 July 2024 | ||||
|---|---|---|---|---|
| Sterling £'000 |
US Dollar £'000 |
Euro £'000 |
Total £'000 |
|
| Investments | 2,197 | 306,805 | – | 309,002 |
| Unrealised derivative assets | – | 4,866 | – | 4,866 |
| Cash and cash equivalents | 479 | 7,585 | (877) | 7,187 |
| Cash collateral receivable from brokers | 8,457 | 7,111 | 803 | 16,371 |
| Unrealised derivative liabilities | – | (2,535) | (713) | (3,248) |
| Other net liabilities | (79) | – | – | (79) |
| 11,054 | 323,832 | (787) | 334,099 | |
For the year ended 31 July 2024
| As at 31 July 2023 | ||||
|---|---|---|---|---|
| Sterling £'000 |
US Dollar £'000 |
Euro £'000 |
Total £'000 |
|
| Investments | 1,641 | 186,623 | – | 188,264 |
| Unrealised derivative assets | – | 4,522 | 1,158 | 5,680 |
| Cash and cash equivalents | 6,450 | 10,865 | (266) | 17,049 |
| Cash collateral receivable from brokers | 6,746 | 5,214 | 226 | 12,186 |
| Unrealised derivative liabilities | – | (1,232) | (179) | (1,411) |
| Cash collateral payable to brokers | (259) | – | – | (259) |
| Other net liabilities | (130) | – | – | (130) |
| 14,448 | 205,992 | 939 | 221,379 |
The Company constantly monitors currency rate risk to ensure balances, wherever possible, are translated at rates favourable to the Company.
Credit risk is the risk of financial loss to the Company if the contractual party to a financial instrument fails to meet its contractual obligations.
The maximum exposure to credit risk as at 31 July 2024 was £28,843,000 (2023: £35,062,000). The calculation is based on the Company's credit risk exposure as at 31 July 2023 and this may not be representative for the whole year.
The Company's quoted investments are held on its behalf by the Prime Brokers. Bankruptcy or insolvency of the Prime Brokers may cause the Company's rights with respect to securities held by the Prime Brokers to be delayed. The Manager and the Board monitor the Company's risk and exposures.
Where the Manager makes an investment in a bond, corporate or otherwise, the credit worthiness of the issuer is taken into account so as to minimise the risk to the Company of default. The credit standing and other associated risks are reviewed by the Manager.
Investment transactions are carried out with a number of brokers where creditworthiness is reviewed by the Manager.
Cash is only held at banks that have been identified by the Board as reputable and of high credit quality. The Manager reviews these on a continual basis with regular updates to the Board.
Capital management policies The structure of the Company's capital is noted in the Statement of Changes in Equity and managed in accordance with the investment objective and policy set out in the Strategic Report.
The Company's capital management objectives are to maximise the return to Shareholders while maintaining a capital base to allow the Company to operate effectively and meet obligations as they fall due.
The Board, with the assistance of the Manager, monitors and reviews the capital on an ongoing basis.
The Company is subject to externally imposed capital requirements:
These requirements are unchanged since last year and the Company has complied with them at all times.
A sensitivity analysis has not been prepared for interest risk, as the Company is not materially exposed to interest rates.
MLCM, a company controlled by Mr Mark Sheppard, is the Manager and AIFM of the Company. Mr Sheppard is also a director of MMIC, which is the controlling Shareholder of the Company.
The Manager receives a monthly management fee for these services which in the year under review amounted to a total of £1,458,000 (2023: £532,000) excluding VAT. The balance owing to the Manager as at 31 July 2024 was £218,000 (2023: £52,000).
Details relating to the Directors' emoluments are found in the Directors' Remuneration Report on page 48.
The ultimate controlling Shareholder throughout the year and the previous year was MMIC, a company incorporated in the UK and registered in England and Wales. This company was controlled throughout the year and the previous year by Mr Mark Sheppard and his immediate family.
A copy of the financial statements of MMIC can be obtained from the Company's website: www.mlcapman.com/manchester-london-investment-trust-plc.
There are no post balance sheet events to report.
Active share is a measure of the percentage of stock holdings in a manager's portfolio that differ from the comparative benchmark index. It is calculated by summing the absolute differences between benchmark and portfolio holdings' weights, then dividing by two (to eliminate double counting). An active share of 100 indicates no overlap with the index and an active share of zero indicates a portfolio that tracks the index (when using leverage, maximum active share levels can exceed 100%).
An APM is a numerical measure of the Company's current, historical or future financial performance, financial position or cash flows, other than a financial measure defined or specified in the applicable financial framework. In selecting these Alternative Performance Measures, the Directors considered the key objectives and expectations of typical investors in an investment trust such as the Company.
Delta measures the degree to which an option is exposed to shifts in the price of the underlying asset (i.e. stock) or commodity (i.e. futures contract). Values range from 1.0 to –1.0 (or 100 to –100, depending on the convention employed). See website link for further details: https://mlcapman.com/faq/
Delta times the underlying security's notional exposure for options. For all other instruments, the notional exposure of the security. At the sector and portfolio levels, this is the sum of the individual security delta adjusted exposures. See website link for further details: https://mlcapman.com/faq/
If the Share price is lower than the NAV per Share it is said to be trading at a discount. The size of the discount is calculated by subtracting the Share price from the NAV per Share and is usually expressed as a percentage of the NAV per Share. If the Share price is higher than the NAV per Share, this situation is called a premium.
Gearing refers to the level of the Company's debt to its equity capital. The Company may borrow money to invest in additional investments for its portfolio. If the Company's assets grow, the Shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets.
Gearing represents borrowings at par less cash and cash equivalents (including any outstanding trade or foreign exchange settlements) expressed as a percentage of Shareholders' funds.
Potential gearing is the Company's borrowings expressed as a percentage of Shareholders' funds.
Under the AIFMD it is necessary for AIFs to disclose their leverage in accordance with the prescribed calculations of the Directive. Leverage is often used as another term for gearing which is included within the Strategic Report. Under the AIFMD there are two types of leverage that the AIF is required to set limits for, monitor and periodically disclose to investors. The two types of leverage calculations defined are the gross and commitment methods. These methods summarily express leverage as a ratio of the exposure of debt, non-sterling currency, equity or currency hedging and derivatives exposure against the net asset value. The difference between the two methods is that the commitment method nets off derivative instruments and the gross method aggregates them.
The NAV is Shareholders' funds expressed as an amount per individual Share. Shareholders' funds are the total value of all the Company's assets, at a current market value, having deducted all liabilities and prior charges at their par value (or at their asset value). The total NAV per Share is calculated by dividing the NAV by the number of Shares in issue excluding Treasury Shares.
Prime brokerage is the bundling of services by investment banks enabling the Company to borrow securities and cash in order to be able to invest on a netted basis and achieve an absolute return. The Prime Broker provides custody and a centralised securities clearing facility for the Company so the Company's collateral requirements are netted across all deals handled by the Prime Broker.
As recommended by the AIC, ongoing charges are the Company's annualised expenses including (excluding finance costs, variable management fee and certain non-recurring items) expressed as a percentage of the average monthly net assets of £281,638,000. The ongoing charges ratio is 0.47%.
Total assets include investments, cash, current assets and all other assets. An asset is an economic resource, being anything tangible or intangible that can be owned or controlled to produce value and to produce positive economic value. Assets represent the value of ownership that can be converted into cash. The total assets less all liabilities will be equivalent to total Shareholders' funds.
Rounding throughout this annual report is done on a line by line basis not a total basis.

Total return statistics enable the investor to make performance comparisons between investment trusts with different dividend policies. The total return measures the combined effect of any dividends paid, together with the rise or fall in the Share price or NAV. This is calculated by the movement in the NAV or Share price plus dividend income reinvested by the Company at the prevailing NAV or Share price.
| NAV Total Return | Page | 31 July 2024 |
31 July 2023 |
|
|---|---|---|---|---|
| Closing NAV per Share (p) | 3 | 831.24 | 550.79 | |
| Total dividends paid in the year ended 31 July 2024 (2023) (p) |
21.00 | 14.00 | ||
| Adjusted closing NAV (p) | 852.24 | 564.79 | a | |
| Opening NAV per Share (p) | 3 | 550.79 | 493.04 | b |
| NAV total return unadjusted (c=((a-b)/b)) (%) |
54.73 | 14.55 | c | |
| NAV total return adjusted (%)* | 3/4 | 55.44 | 15.34 |
* Based on NAV price movements and dividends reinvested at the relevant cum dividend NAV value during the period. Where the dividend is invested and the NAV value falls this will further reduce the return or, if it rises, any increase will be greater. The source is Bloomberg who have calculated the return on an industry comparative basis.
This document is important and requires your immediate attention. If you are in any doubt as to any aspect of the proposals referred to in this document or as to the action you should take, you should consult your stockbroker, bank manager, solicitor, accountant or other independent professional adviser authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if not, from another appropriately authorised independent professional adviser, without delay.
If you have sold or transferred all of your Ordinary Shares in the capital of the Company and, as a result, no longer hold any Ordinary Shares in the Company, please send this document as soon as possible to the purchaser or transferee, or to the person through whom the sale or transfer was effected for transmission to the purchaser or transferee. If you have sold only part of your holding of Ordinary Shares in the Company, you should retain the documents and consult the person through whom the sale was effected.
Pursuant to Article 52.2 of the Company's Articles of Association (the "Articles"), the Board has determined that the Annual General Meeting will be held wholly by means of an Electronic Facility (as defined in the Articles) namely by a live webcast. Full details are set out in the Letter from the Chairman. Shareholders will be able to attend the meeting virtually. Explanations and definitions of abbreviations can be found in the Glossary of the latest Annual Report and the Articles.
The Board encourages Shareholders to vote electronically or to appoint the Chairman of the meeting as their proxy with their voting instructions. You may appoint a proxy online via www.signalshares.com. If shares are not held directly, Shareholders are encouraged to arrange for their nominee to vote on their behalf and appoint a proxy via the CREST system. To be valid, any form of proxy or other instrument appointing a proxy must be received by post or (during normal business hours only) by hand at the Company's Registrar, at the address shown on the form of proxy, or in the case of shares held through CREST, via the CREST system, or if submitting the proxy vote electronically, via the Registrar's website, by no later than 12.00 noon on Monday, 4 November 2024.

(the "Company")
(registered in England and Wales under number 01009550 with 12a Princes Gate Mews, London, England, SW7 2PS as registered address)
Notice of the fifty second Annual General Meeting of the Company to be held virtually at 12.00 noon GMT on Wednesday, 6 November 2024

Dear Shareholder,
I am pleased to advise that the fiftieth Annual General Meeting ("AGM") of the Company will be held by means of an Electronic Facility on Wednesday, 6 November 2024 at 12.00 noon.
The Company understands and respects the importance of the AGM to shareholders and the Company will offer shareholders the option to ask questions in advance of the meeting. The 2024 AGM will be a fully virtual meeting by means of an electronic facility and Shareholders are invited to participate in the AGM electronically via Microsoft Teams. Further details are set out on page 98. Please contact the Manager who will provide further information. Shareholders are asked to exercise their votes by submitting their proxy electronically in advance of the meeting and to appoint the Chairman of the meeting as their proxy with their voting instructions. Further details of how you can vote are set out on pages 98 and 99.
The formal Notice of the AGM, which follows this letter, sets out the business to be considered at the meeting. Shareholders are being asked to vote on various items of business, being: the receipt and acceptance of the Annual Report and the Financial Statements for the year ended 31 July 2024; the approval of the Directors' Remuneration Report, the approval of the Remuneration Policy; the approval of the final ordinary dividend; the election and re-election of Directors; the re-appointment of Deloitte LLP as Auditor; the authorisation of the Directors to determine the remuneration of the Auditor; the authorisation of the Directors to offer scrip dividends; the authorisation of the Directors to allot Ordinary Shares and disapply statutory pre-emption rights for certain issues of Ordinary Shares; the authorisation of the Company to make market purchases of Ordinary Shares; the authorisation for the sale of Treasury Shares at a discount to Net Asset Value ("NAV"); and the holding of general meetings (other than annual general meetings) on not less than 14 clear days' notice.
Resolutions 1 to 12 will be proposed as ordinary resolutions and resolutions 13 to 16 will be proposed as special resolutions.
The Directors are required to present to the meeting the Company's Strategic Report, Directors' Report, Auditor's Report and the audited financial statements for the financial year ended 31 July 2024 (the "Annual Report and Financial Statements"). These are contained in the Annual Report of the Company for such period.
The Directors' Remuneration Report for the year ended 31 July 2024 is set out on pages 48 to 51 of the Annual Report and Financial Statements. In accordance with Companies Act 2006 (the "Act"), this vote to approve the Remuneration Report is advisory only and the Directors' entitlement to receive remuneration is not conditional on it. The resolution and vote are a means of providing Shareholder feedback to the Board.
The Directors' Remuneration Policy is set out on page 52 of the Annual Report and Accounts. The Policy is unchanged since it was presented at the AGM of the Company held on 1 November 2023. This resolution is binding in nature and, if approved, will take effect from the conclusion of the AGM. Renewal of the policy is required to be sought at intervals of at least three years, or earlier if there are any changes to the Policy, and the Policy will next be submitted to Shareholders for approval no later than the 2027 AGM. Notwithstanding this, the Board wishes to put the Policy to Shareholders for approval annually.
The final ordinary dividend for the year ended 31 July 2024, as recommended by the Directors, is 7 pence per Share. If approved by Shareholders at the forthcoming AGM, this final dividend will be paid on 8 November 2024 to Shareholders on the register at the close of business on 4 October 2024. The ex-dividend date will be 4 October 2024.
In line with the UK Corporate Governance Code (the "UK Code"), the Board has agreed a policy whereby all Directors will seek annual re-election at the Company's AGMs. In line with this policy, Daniel Wright, Brett Miller, Daren Morris and James Waterlow will stand for re-election.
Mr Wright has no previous relationship with the Company other than his position as an independent non-executive Director, nor with the controlling Shareholder of the Company or any associate of the controlling Shareholder of the Company within the meaning of Listing Rule 10.6.16 R. In addition to being satisfied that Mr Wright is independent of the controlling Shareholder, the other Directors have also determined that he satisfies all the other independence criteria in the UK Code.
Mr Miller is head of compliance, governance and risk oversight, holds the SMF16 and SMF17 roles under the Senior Managers and Certification Regime and sits on the risk management committee of M&L Capital Management Limited, the Company's Manager. He is therefore not deemed to be independent of the Manager.
Neither Mr Morris, nor Sir James have previous relationships with the Company other than their position as independent non-executive Directors, and Mr Morris as Audit Committee Chair. Sir James and Mr Morris have no connections with the controlling Shareholder of the Company or any associate of the controlling Shareholder of the Company within the meaning of Listing Rule 10.6.16 R.
M&M Investment Company Limited, which is controlled by Mark Sheppard who forms part of the investment management team at M&L Capital Management Limited, is the controlling Shareholder of the Company (further details can be found on page 31 of the Annual Report). The Listing Rules require independent non-executive directors of Main Market listed companies that have a controlling shareholder to be re-elected by a majority of the votes cast by the independent Shareholders of the Company, as well as by a majority of the votes cast by all the Shareholders. In the case of the Company, 'independent Shareholders' mean all the Shareholders of the Company other than M&M Investment Company Limited.
Accordingly, the votes cast by the independent Shareholders and by all the Shareholders for the resolutions for the re-election of Mr Wright, Mr Morris and Sir James (Resolutions 5, 6, 7 and 8) will be calculated separately. Such a resolution will be passed only if a majority of the votes cast by the independent Shareholders are in favour, in addition to a majority of the votes cast by all the Shareholders being in favour. If the resolution to approve the re-election of Mr Wright, Mr Morris or Sir James is passed, but separate approval by the independent Shareholders is not given, the Listing Rules permit the Director to remain in office pending a further resolution to be approved by all Shareholders, at a meeting which must be held more than 90 days, but within 120 days, of the first votes.
The Chairman and the Board confirm that, following formal performance evaluations, the performance of each of the Directors continues to be effective and demonstrates commitment to the role and having considered the Directors' other time commitments and board positions, are satisfied that each Director has the capacity to be fully engaged with the Company's business. The Chairman and the Board therefore believe that it is in the interests of Shareholders that each of the Directors standing for re-election and election are elected. Directors' biographical details can be found in the Annual Report on page 28.
Auditors must be appointed at each general meeting at which the Annual Report and Financial Statements are presented to Shareholders. An assessment of the independence and objectivity of Deloitte LLP has been undertaken by the Audit Committee; it has recommended to the Board that a resolution for the re-appointment of Deloitte LLP as the Company's Auditor be put to Shareholders at the forthcoming AGM. Further details about the performance of the Auditor can be found on page 47 of the Annual Report. Resolution 10, if passed, would authorise the Directors to determine the level of Auditor's remuneration.
The Directors are proposing to obtain the authority to offer an optional scrip dividend to Shareholders in future periods. Scrip dividends are subject to Shareholder approval and Resolution 11 is being proposed at the AGM to obtain that approval. The authority contained in Resolution 11 is to expire at the conclusion of the annual general meeting of the Company to be held in 2025.
Unless circumstances change, the Directors would expect to renew this authority annually at the annual general meetings of the Company. Details of how any scrip dividend scheme would operate will be released to Shareholders if such an option is actually offered in the future.
Resolution 12, an ordinary resolution, as set out in the notice of meeting, if passed, will renew the Directors' authority to issue up to an aggregate nominal value of £2,507,938, representing 10,031,754 Ordinary Shares (being approximately one-quarter of the issued share capital (excluding Treasury Shares) as at 20 September 2024), in accordance with statutory pre-emption rights. The authority, if given, will lapse at the conclusion of the next annual general meeting of the Company after the passing of this resolution (which must be held no later than 31 January 2026). The authority will be used where Directors consider it to be in the best interests of Shareholders. The Directors will only issue new Ordinary Shares at a price at or above the prevailing net asset value per Ordinary Share.
As at 20 September 2024, 401,220 Shares were held in Treasury.
Resolution 13, a special resolution, if passed, will renew the Directors' authority to disapply the statutory pre-emption rights of existing Shareholders in relation to the issue of Ordinary Shares for cash or the sale of Ordinary Shares out of Treasury up to an aggregate nominal amount of £1,003,175 (being approximately 10% of the issued share capital (excluding Treasury Shares) as at 20 September 2024). This authority, if given, will expire at the next annual general meeting, when a resolution for its renewal will be proposed. The authority will be used where Directors consider it to be in the best interests of Shareholders. Any Ordinary Shares issued on a non-pre-emptive basis under this authority will be issued at a price at or above the prevailing NAV per Ordinary Share. The passing of Resolution 13 is subject to the passing of Resolution 12.
Subject to the passing of Resolution 13, Resolution 14 will renew the Company's authority to sell Shares from Treasury at a discount to NAV. Treasury Shares may only be sold at a discount to NAV per Share if that discount does not exceed the weighted average discount to NAV per Share at which the Shares were purchased and provided that any Shares sold from Treasury for cash are sold at higher prices (including expenses) than the weighted average price at which those Shares were bought into Treasury.
At the annual general meeting held on 1 November 2023, the Company was granted authority to purchase up to 14.99% of the Company's Ordinary Shares in issue (excluding Treasury Shares) amounting to 6,024,933 Ordinary Shares. Since September 2021, the highest price the Company has paid for shares held in Treasury was 666 pence. The average cost per share of the shares held in Treasury was 549 pence. As at 31 July 2024, the share price was 704 pence. As at 20 September 2024, 66,000 Shares have been bought back under this authority.
Resolution 15, which will be proposed as a special resolution, seeks to renew the authority granted at last year's annual general meeting and gives the Company authority to buy back its own Shares in the market. The authority limits the number of Ordinary Shares that could be purchased to a maximum of 6,015,040 (representing 14.99% of the issued Ordinary Share capital of the Company (excluding Treasury Shares) as at the close of business on 20 September). The authority sets out the minimum and maximum prices. This authority will expire at the conclusion of the next annual general meeting of the Company.
Whilst the Directors have no present intention of using this authority, the Directors would use this authority in order to address any imbalance between the supply and demand for the Ordinary Shares and to manage the discount to NAV at which the Ordinary Shares trade. When proposing this resolution the Directors have considered the following: the Company does not capitalize any operational (non-Equity Swap Finance) costs, the Manager's fee structure is viewed as competitive when compared to similarly invested, actively managed, investment trust companies, and the Directors believe that the discount is a function of the size of the Company, the liquidity of its shares, and the Ten Year US Treasury yield.
Any purchases of Shares would be by means of market purchases through the London Stock Exchange or other available exchanges. Any Shares purchased pursuant to this authority may either be held as Treasury Shares or cancelled by the Company, as determined by the Directors at the time of purchase. The authority will only be used after careful consideration, taking into account market conditions prevailing at the time, other investment opportunities, appropriate gearing levels and the overall financial position of the Company.
Under the Act, the notice period required for all general meetings of a company is 21 days. Annual general meetings will always be held on at least 21 clear days' notice but Shareholders can approve a shorter notice period for other general meetings, provided this is not less than 14 clear days. Such a notice period provides flexibility and, if approved, will remain effective until the next annual general meeting of the Company, when it is intended that a similar resolution will be proposed. The Directors will only call general meetings on 14 clear days' notice where they consider it in the best interests of Shareholders to do so and the relevant matter requires to be dealt with expediently.
Shareholders are permitted to attend the AGM virtually. The Board recognises that the AGM represents an important forum for Shareholders to ask questions and virtual annual general meetings allow a methodology for more shareholders to attend the meeting (up to 1,000) for a lower cost (including travel costs and carbon footprint) and hence the Board believes virtual meetings are more inclusive than physical meetings. The Teams platform is a product of Microsoft Corp., which is the Company's largest investment holding, so this will be a great opportunity for Shareholders to get first-hand experience of a Microsoft product.
You are encouraged to appoint a proxy online via www.signalshares.com. Alternatively, if you hold your shares in CREST, you may appoint a proxy via the CREST system. Notice of your appointment of a proxy should reach the Company's Registrar, Link Group by 12.00 noon on Monday, 4 November 2024. If you hold your shares through a nominee service, please contact the nominee service provider regarding the process for appointing a proxy and encourage them to vote electronically without delay.
If you would like to attend the AGM virtually, please email (with Subject Line: Request to Join vAGM) your details to [email protected] with proof that you are a Shareholder or you have a Letter of Authority from the nominee company that you hold shares with. You will receive a personal email with the Teams Invite for the meeting.
You can join via Teams in the 15 minutes before the AGM from any device, whether or not you have a Teams account. If you don't have an account, follow these steps to join as a guest.
| Join Microsoft Teams Meeting | |
|---|---|
Go to the meeting invite and select Join Microsoft Teams Meeting.
If you have a family member who is already a subscriber to Teams why not have a practice run with your own family meeting with them?
When the AGM opens at the appointed time, you will be able to see and hear the Chairman. The Chairman will open the AGM and address all questions that have been submitted in advance. There will be a short opportunity to ask any further questions. Then the Chairman will ask if anyone wishes to vote using the Poll Card (please do not elect to do so if you have already voted by Proxy and do not wish to change your vote). If anyone does wish to vote by Poll Card, the process of how and when to vote using a Poll Card will be explained and Poll Card votes will be accepted throughout the AGM and the following 30 minutes after the AGM.
The Chairman will then formally put each resolution to the AGM and advise of the proxy votes already received in advance.
The Manager will then say a few words about the Portfolio and the Financial markets. A further opportunity will then be provided to ask the Manager questions.
The AGM will then formally close.
The results of the AGM will be announced by an RNS and posted to the Company's website: https://mlcapman.com/manchester-london-investment-trust-plc/
There will be an opportunity to download, complete, sign and submit poll cards at the Virtual meeting but the Board encourages Shareholders to vote electronically and to appoint the Chairman of the meeting as their proxy with their voting instructions. You will find instructions in the notes to the notice to enable you to vote electronically via www.signalshares.com and how to register to do so. All valid proxy votes will be included in the voting. The ability to vote by Poll Card will close 30 minutes after the close of the AGM.
Shareholders are also invited to ask questions at the AGM. The Board invites Shareholders to submit any questions they may have for the virtual AGM by email (with Subject Line: Question for vAGM) to [email protected]. The Manager will endeavor to answer your question or get an answer to your question and provide that to you personally before the AGM but the Chairman will also post your question at the AGM, identify you as the person who formed the question and any reply provided to you. If you do have a specific question whilst the AGM is in progress then use the "Raise Hand" function in the "Reactions" menu on the Teams Meeting platform or by typing the question through the Chat function on the Teams platform. You will be kept on mute by the AGM host until you are invited to speak/ask your question(s).
The Board considers all the resolutions to be proposed at the AGM to be in the best interests of Shareholders and the Company as a whole. Accordingly, the Directors unanimously recommend that all Shareholders vote in favour of the resolutions, as they intend to do in respect of their own shareholdings.
If you have not already done so we suggest you provide your email to the Registrars investor relations site by logging on to www.signalshares.com AND providing your email to the Manager at [email protected] if you wish to receive the Fund Factsheet monthly.
Yours faithfully,
Daniel Wright Chairman 25 September 2024
Notice is hereby given that the Annual General Meeting (the "AGM") of Manchester and London Investment Trust plc (the "Company") will be held virtually on Wednesday, 6 November 2024 at 12.00 noon.
Resolutions 1 to 12 (inclusive) will be proposed as ordinary resolutions, which means that for each of these to be passed, more than 50% of the votes cast must be in favour of the resolution. Resolutions 13 to 16 will be proposed as special resolutions, meaning that for each of these to be passed, at least 75% of the votes cast must be in favour.
Each of the resolutions to be considered at the AGM will be voted on by way of a poll. This ensures that, if shareholders are unable to attend the AGM but have appointed proxies, their votes are taken into account. The results of the polls will be announced to the London Stock Exchange and published on the Company's website as soon as possible after the conclusion of the AGM.
THAT, the Directors of the Company be and are hereby generally and unconditionally authorised, in addition to any existing authorities, pursuant to and in accordance with Section 551 of the Companies Act 2006 (the "Act") to exercise all the powers of the Company to allot Ordinary Shares of 25 pence each in the capital of the Company ("Ordinary Shares"), up to an aggregate nominal amount of £2,507,938, representing 10,031,754 Ordinary Shares (being approximately one-quarter of the issued share capital (excluding Treasury Shares) as at 20 September 2024), such authority to expire at the next annual general meeting of the Company after the passing of this resolution (unless previously revoked or varied by the Company in a general meeting), save that the Company may, at any time prior to the expiry of such authority, make an offer or enter into an agreement which would or might require Ordinary Shares to be allotted and the Directors may allot Ordinary Shares in pursuance of such an offer or agreement as if the authority conferred hereby had not expired.
By order of the Board
Daniel Wright Chairman 25 September 2024 Registered Office: 12a Princes Gate Mews London SW7 2PS
The statements of the rights of members in relation to the appointment of proxies in note 2 above do not apply to a Nominated Person. The rights described in this note can only be exercised by registered members of the Company.
Mr Wright was appointed to the Board on 29 October 2018, so he has served on the Board as an independent non-executive director for six years. Mr Wright was appointed as Chairman of the Board on 26 November 2021.
Director of SolasCure Limited.
Executive Chairman of Science in Sport Plc.
Non-Executive Chairman of Uinsure Group Holdings.
Mr Wright was previously the founding partner, chief operating officer and head of portfolio at NorthEdge Capital, executive chairman of Accrol Group Holdings Plc and Chairman of Vision Support Services Group Limited, a private company that he founded and grew to become Europe's leading distributor of textiles to the hospitality sector.
He has also held previous roles at Cable Partners LLC, Deutsche Morgan Grenfell Private Equity and The Royal Bank of Scotland.
Mr Wright graduated from the University of Cambridge and qualified as a chartered accountant with Arthur Andersen in 1996.
What we value: Experienced Chairman with deep understanding of how companies work, Accounting knowledge, Interest in International affairs and geo-politics. Dan has an interest in 149,542 (95,086 of which held by PCAs) shares in the company.
Mr Morris was appointed to the Board of the Company and as Chairman of the Audit Committee on 10 December 2021. He is also the Company's Senior Independent Director.
CFO of Big Technologies PLC, a company listed on AIM and active in the provision of advanced technology for the electronic monitoring of individuals. Previously CFO of Volex PLC from 2015 to 2020. Spent the first 18 years of his career in investment banking and accountancy and was a Managing Director at both UBS Investment Bank and Morgan Stanley. Mr Morris's other public company board experience includes Big Technologies plc, Volex plc, Easynet plc and Nexen Tech Corporation.
Mr Morris is a qualified chartered accountant (ICAEW ACA 1997) and graduated in Physics from Trinity College, Oxford.
What we value: Mr Morris has done an excellent job as Chairman of the Audit Committee. He has a highly impressive CV of public company and City experience. He has an interest in 38,000 shares in the company.

Mr Miller was appointed to the Board on 30 August 2013, so he has served on the Board for 11 years. Mr Miller is not a member of the Audit Committee.
Director of Ecofin US Renewables Infrastructure Trust plc.
Director of SLF Realisation Fund Limited.
Mr Miller graduated from the University of the Witwatersrand (South Africa) with a Bachelors degree majoring in law and economics and additionally holds a law degree from the London School of Economics. He qualified as a solicitor and practised until 1997. Mr Miller is head of compliance, governance and risk oversight, holds the SMF16 and SMF17 roles under the Senior Managers and Certification Regime and also sits on the risk management committee of MLCM, the Company's Manager.
What we value: Long service with deep knowledge of the last decade of the Company's history, Legal knowledge, Extensive public company knowledge. Mr Miller has an interest of 1,734 shares in the company.
Sir James Waterlow was appointed to the Board on 17 August 2020. Sir James Waterlow is a member of the Audit Committee.
Specialised in investment trusts for thirty years, for the past fifteen as a partner on the Investment Funds team at Singer Capital Markets. During his career he has advised approximately 30 investment trust boards and worked on a significant number of transactions, raising over £5 billion for new and existing funds.
Sir James graduated from the University of Exeter.
What we value: Very useful understanding of the Investment Trust Company sector as it develops in context to both regulatory and market events. Extensive contacts with Investors in Investment Funds. Sir James has an interest in 15,000 shares in the company.
The Directors are shareholders like you. They are hardworking and dedicated and we ask you for your support in their re-appointment.


The Company's NAV is released to the London Stock Exchange on a weekly basis.
Copies of the Company's annual and half-yearly reports, factsheets and further information on the Company can be obtained from its website: www.mlcapman.com/manchester-london-investment-trust-plc.
| Company's year end | 31 July 2024 |
|---|---|
| Annual results announced | 25 September 2024 |
| Ex-dividend date | 3 October 2024 |
| Record date | 4 October 2024 |
| Annual General Meeting | 6 November 2024 |
| Final dividend payment date | 8 November 2024 |
| Company's half-year end | 31 January 2025 |
| Half-yearly results announced | March 2025 |
Shareholders now have the opportunity to be notified by email when the Company's annual reports, half-yearly reports and other formal communications are available on the Company's website, instead of receiving printed copies by post. This has environmental benefits in the reduction of paper, printing, energy and water usage, as well as reducing costs to the Company. If you have not already elected to receive electronic communications from the Company and wish to do so, visit www.signalshares.com. To register, you will need your investor code, which can be found on your share certificate or your dividend confirmation statement.
Alternatively, you can contact Link's Customer Support Centre, which is available to answer any queries you have in relation to your shareholding:
By phone: call 0371 664 0300 (calls cost 12 pence per minute plus your phone company's access charge. Calls outside the UK will be charged at the applicable international rate. Link is open between 09:00 – 17:30, Monday to Friday excluding public holidays in England and Wales).
By email: [email protected]
By post: Link Group
Central Square 29 Wellington Street Leeds LS1 4DL
Daniel Wright (Chairman) Brett Miller Sir James Waterlow Daren Morris (Audit Committee Chairman)
M&L Capital Management Limited 12a Princes Gate Mews London SW7 2PS Email: [email protected]
Link Company Matters Limited Central Square 29 Wellington Street Leeds LS1 4DL
Link Group Central Square 29 Wellington Street Leeds LS1 4DL Tel: 0371 664 0300 Email: shareholder.enquiries@ linkgroup.co.uk
Deloitte LLP 110 Queen Street Glasgow G1 3BX
Link Alternative Fund Administrators Limited Broadwalk House Southernhay West Exeter EX1 1TS
National Westminster Bank plc 11 Spring Gardens Manchester M60 2DB
Indos Financial Limited The Scalpel 18th Floor 52 Lime Street London EC3M 7AF Tel: 020 3876 2225
JP Morgan Securities PLC 25 Bank Street Canary Wharf London E14 5JP Tel: 020 7134 8584
Morgan Stanley & Co International PLC 25 Cabot Square Canary Wharf London E14 4QA Tel: 020 7425 8000
Registered in England and Wales Number: 01009550
Registered Office
12a Princes Gate Mews London SW7 2PS
www.mlcapman.com/manchester-london-investment-trust-plc



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.